<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://embryology.med.unsw.edu.au/embryology/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Z3462124</id>
	<title>Embryology - User contributions [en-gb]</title>
	<link rel="self" type="application/atom+xml" href="https://embryology.med.unsw.edu.au/embryology/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Z3462124"/>
	<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Special:Contributions/Z3462124"/>
	<updated>2026-05-13T03:52:37Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.39.10</generator>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220527</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220527"/>
		<updated>2016-03-13T23:26:17Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220395</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220395"/>
		<updated>2016-03-10T01:38:02Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===How to make an in-text citation===&lt;br /&gt;
&lt;br /&gt;
Bacterial division protein Ftsz. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Testz8600021]]&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
[https://cellbiology.med.unsw.edu.au/cellbiology/index.php/2010_Lecture_1 Lecture 1]&lt;br /&gt;
&lt;br /&gt;
[https://www.biomedcentral.com/ BioMed Central]&lt;br /&gt;
&lt;br /&gt;
===What I have learned so far...===&lt;br /&gt;
&lt;br /&gt;
Today we began learning about how to correctly code information on the wikipedia page. After creating a Test Student page, we recorded our lab attendance using a simple code under the subheading &amp;quot;lab attendance&amp;quot;. We then began accumulating a number of links to different external sources and learning how to code the information to allow for easy access and a neat page.  &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;reference/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220225</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220225"/>
		<updated>2016-03-10T01:34:33Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===How to make an in-text citation===&lt;br /&gt;
&lt;br /&gt;
Bacterial division protein Ftsz. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Testz8600021]]&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
[https://cellbiology.med.unsw.edu.au/cellbiology/index.php/2010_Lecture_1 Lecture 1]&lt;br /&gt;
&lt;br /&gt;
[https://www.biomedcentral.com/ BioMed Central]&lt;br /&gt;
&lt;br /&gt;
===What I have learned so far...===&lt;br /&gt;
&lt;br /&gt;
Today we began learning about how to correctly code information on the wikipedia page. After creating a Test Student page, we recorded our lab attendance using a simple code under the subheading &amp;quot;lab attendance&amp;quot;. We then began accumulating a number of links to different external sources and learning how to code the information to allow for easy access and a neat page.  &lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220117</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=220117"/>
		<updated>2016-03-10T01:31:52Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===How to make an in-text citation===&lt;br /&gt;
&lt;br /&gt;
Bacterial division protein Ftsz. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
[https://cellbiology.med.unsw.edu.au/cellbiology/index.php/2010_Lecture_1 Lecture 1]&lt;br /&gt;
&lt;br /&gt;
[https://www.biomedcentral.com/ BioMed Central]&lt;br /&gt;
&lt;br /&gt;
===What I have learned so far...===&lt;br /&gt;
&lt;br /&gt;
Today we began learning about how to correctly code information on the wikipedia page. After creating a Test Student page, we recorded our lab attendance using a simple code under the subheading &amp;quot;lab attendance&amp;quot;. We then began accumulating a number of links to different external sources and learning how to code the information to allow for easy access and a neat page.  &lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219985</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219985"/>
		<updated>2016-03-10T01:24:31Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
[https://cellbiology.med.unsw.edu.au/cellbiology/index.php/2010_Lecture_1 Lecture 1]&lt;br /&gt;
&lt;br /&gt;
[https://www.biomedcentral.com/ BioMed Central]&lt;br /&gt;
&lt;br /&gt;
===What I have learned so far...===&lt;br /&gt;
&lt;br /&gt;
Today we began learning about how to correctly code information on the wikipedia page. After creating a Test Student page, we recorded our lab attendance using a simple code under the subheading &amp;quot;lab attendance&amp;quot;. We then began accumulating a number of links to different external sources and learning how to code the information to allow for easy access and a neat page.  &lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219871</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219871"/>
		<updated>2016-03-10T01:15:50Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
[https://cellbiology.med.unsw.edu.au/cellbiology/index.php/2010_Lecture_1 Lecture 1]&lt;br /&gt;
&lt;br /&gt;
[https://www.biomedcentral.com/ BioMed Central]&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219705</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219705"/>
		<updated>2016-03-10T01:12:30Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
[https://cellbiology.med.unsw.edu.au/cellbiology/index.php/2010_Lecture_1 Lecture 1]&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219597</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219597"/>
		<updated>2016-03-10T01:10:20Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Links===&lt;br /&gt;
&lt;br /&gt;
[[Carnegie stage table]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219509</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219509"/>
		<updated>2016-03-10T01:07:26Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26756351&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219433</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219433"/>
		<updated>2016-03-10T01:05:24Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
PMID 26756351&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219297</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219297"/>
		<updated>2016-03-10T01:02:38Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton eukaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219245</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219245"/>
		<updated>2016-03-10T01:01:56Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton prokaryotic cytoskeleton]&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219189</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219189"/>
		<updated>2016-03-10T01:00:44Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
===Search Pubmed===&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219107</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219107"/>
		<updated>2016-03-10T00:59:57Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pubmed/?term=eukaryotic+cytoskeleton&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219067</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=219067"/>
		<updated>2016-03-10T00:58:57Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pubmed/?term=prokaryotic+cytoskeleton&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=218985</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=218985"/>
		<updated>2016-03-10T00:56:17Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Lab Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab 1 Assessment==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=218871</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=218871"/>
		<updated>2016-03-10T00:54:00Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
==Attendance==&lt;br /&gt;
&lt;br /&gt;
[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 11:53, 10 March 2016 (AEDT)&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=218819</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=218819"/>
		<updated>2016-03-10T00:52:50Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
== My Student Page ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) (5/5)&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) There were 2 parts to this assessment, you were also supposed to identify the embryonic origin of tooth components. The endocrine paper is a good recent article. (3/5)&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:27, 8 November 2015 (AEST) I like your peer assessment feedback. My only suggestion would be to structure it in a more point-like form and organise as major/minor. (17/20)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:30 , 8 November 2015 (AEST) Lab 10 assessment missing?&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=211059</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=211059"/>
		<updated>2015-11-06T01:07:00Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==CATEI Evaluation==&lt;br /&gt;
&lt;br /&gt;
Q1. Being able to access all the lecture content and lab work throughout the entire course- especially prior to the lectures and labs to have an opportunity to prepare.&lt;br /&gt;
&lt;br /&gt;
Q2. Having the information in a format that was more accessible. I like to print off all my notes for lectures and then add any additional information onto the slides/info during the lecture and it was difficult to do this when we could only access them on the wiki site. The inclusion of a PDF of just the notes would be useful.&lt;br /&gt;
&lt;br /&gt;
Q3. The way that he encouraged student participation in the labs and lectures by consistently asking questions aided in my learning process because it forced me to integrate information to appropriately respond to questions. &lt;br /&gt;
The use of models and videos was really helpful because it's often difficult to visualise concepts that are not easily illustrated.&lt;br /&gt;
&lt;br /&gt;
Q4. Providing examples of questions that will be asked in the end of session exam; perhaps in the course outline we received at the beginning of the semester. &lt;br /&gt;
Setting the weekly assessments before the lab to enable students to complete it immediately after rather than waiting a few days to be updated.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=209841</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=209841"/>
		<updated>2015-10-30T01:07:26Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:07, 30 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208199</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208199"/>
		<updated>2015-10-23T03:00:17Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Spermatogenesis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; .  Spermatozoa also consists of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes &amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa.&amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may affect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested to have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|400px|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24714837&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few common antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
======2. Cerium dioxide nanoparticles (CNPs)======&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
======3. Vitamin E======&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
======4. Vitamin C======&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes). The following shows the simplified steps of performing ICSI, and is also outlined in the video provided. &lt;br /&gt;
*The female is administered various hormones to stimulate ovulation to release an oocyte, then the oocyte or several oocytes are removed and stored.&lt;br /&gt;
*Simultaneously, the males ejaculate is also collected and only a single spermatozoa may be required for fertilisation. &lt;br /&gt;
*Fertilisation is acheived by the directly injecting a spermatozoon into one stored oocyte using a fine needle. &lt;br /&gt;
*After 2 or 3 days, if fertilisation has successfully occured, the embryo will be transferred into the female's uterus to allow for implantation, and hopefully lead to pregnancy &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Current Research===&lt;br /&gt;
&lt;br /&gt;
The research involving male infertility most recently, is surrounding more innovative techniques to identify new and different targets to treat and diagnose the condition. A study performed in September, 2015 investigated the efficacy of using sperm chromatin structure assays to determine fertility in Nigerian men &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A total of 404 men consisting of fertile and unexplained infertile men underwent both semen analysis and sperm chromatin structure assays. Through the measurement of DNA fragmentation index, there was a more significant difference between infertile and fertile men when using sperm chromatin structure assaying &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore this new diagnostic tool may be more accurate in determining the fertility potential of males. Not only does this allow for a more predictive indicator, but it may also lead future research to use modify these technologies and perhaps find the specific molecular and cellular pathways that are affected in each individual male.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ARTs&amp;lt;/b&amp;gt; - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Aetiological factors&amp;lt;/b&amp;gt; - causative agents &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Aneuploidy&amp;lt;/b&amp;gt; - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Cadmium&amp;lt;/b&amp;gt; - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Clomiphene citrate&amp;lt;/b&amp;gt; - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;CNPs&amp;lt;/b&amp;gt; - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;FSH&amp;lt;/b&amp;gt; - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Gametogenesis&amp;lt;/b&amp;gt; - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;GnRH&amp;lt;/b&amp;gt; - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;hCG&amp;lt;/b&amp;gt; - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;hMG&amp;lt;/b&amp;gt; - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Hypogonadatropic hypogonadism&amp;lt;/b&amp;gt; - a condition characterised by a decrease in functional activity of the gonads&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ICSI&amp;lt;/b&amp;gt; - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;IUI&amp;lt;/b&amp;gt; - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;IVF&amp;lt;/b&amp;gt; - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Kiss1&amp;lt;/b&amp;gt; - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Klinefelter syndrome&amp;lt;/b&amp;gt; - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;LH&amp;lt;/b&amp;gt; - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Lipid peroxidation&amp;lt;/b&amp;gt; - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Progressive motility&amp;lt;/b&amp;gt; - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Quenching&amp;lt;/b&amp;gt; - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;RDA&amp;lt;/b&amp;gt; - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ROS&amp;lt;/b&amp;gt; - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogenesis&amp;lt;/b&amp;gt; - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Sperm-reactive antibodies (SpAb)&amp;lt;/b&amp;gt; - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TCM&amp;lt;/b&amp;gt; - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Testicular Dysgenesis Syndrome (TDS)&amp;lt;/b&amp;gt; - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TMS&amp;lt;/b&amp;gt; - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TURED&amp;lt;/b&amp;gt; - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Varicocele&amp;lt;/b&amp;gt; - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208179</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208179"/>
		<updated>2015-10-23T02:56:29Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Structure of spermatozoa */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; .  Spermatozoa also consists of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes &amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may affect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested to have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|400px|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24714837&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few common antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
======2. Cerium dioxide nanoparticles (CNPs)======&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
======3. Vitamin E======&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
======4. Vitamin C======&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes). The following shows the simplified steps of performing ICSI, and is also outlined in the video provided. &lt;br /&gt;
*The female is administered various hormones to stimulate ovulation to release an oocyte, then the oocyte or several oocytes are removed and stored.&lt;br /&gt;
*Simultaneously, the males ejaculate is also collected and only a single spermatozoa may be required for fertilisation. &lt;br /&gt;
*Fertilisation is acheived by the directly injecting a spermatozoon into one stored oocyte using a fine needle. &lt;br /&gt;
*After 2 or 3 days, if fertilisation has successfully occured, the embryo will be transferred into the female's uterus to allow for implantation, and hopefully lead to pregnancy &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Current Research===&lt;br /&gt;
&lt;br /&gt;
The research involving male infertility most recently, is surrounding more innovative techniques to identify new and different targets to treat and diagnose the condition. A study performed in September, 2015 investigated the efficacy of using sperm chromatin structure assays to determine fertility in Nigerian men &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A total of 404 men consisting of fertile and unexplained infertile men underwent both semen analysis and sperm chromatin structure assays. Through the measurement of DNA fragmentation index, there was a more significant difference between infertile and fertile men when using sperm chromatin structure assaying &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore this new diagnostic tool may be more accurate in determining the fertility potential of males. Not only does this allow for a more predictive indicator, but it may also lead future research to use modify these technologies and perhaps find the specific molecular and cellular pathways that are affected in each individual male.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ARTs&amp;lt;/b&amp;gt; - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Aetiological factors&amp;lt;/b&amp;gt; - causative agents &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Aneuploidy&amp;lt;/b&amp;gt; - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Cadmium&amp;lt;/b&amp;gt; - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Clomiphene citrate&amp;lt;/b&amp;gt; - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;CNPs&amp;lt;/b&amp;gt; - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;FSH&amp;lt;/b&amp;gt; - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Gametogenesis&amp;lt;/b&amp;gt; - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;GnRH&amp;lt;/b&amp;gt; - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;hCG&amp;lt;/b&amp;gt; - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;hMG&amp;lt;/b&amp;gt; - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Hypogonadatropic hypogonadism&amp;lt;/b&amp;gt; - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ICSI&amp;lt;/b&amp;gt; - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;IUI&amp;lt;/b&amp;gt; - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;IVF&amp;lt;/b&amp;gt; - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Kiss1&amp;lt;/b&amp;gt; - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Klinefelter syndrome&amp;lt;/b&amp;gt; - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;LH&amp;lt;/b&amp;gt; - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Lipid peroxidation&amp;lt;/b&amp;gt; - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Progressive motility&amp;lt;/b&amp;gt; - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Quenching&amp;lt;/b&amp;gt; - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;RDA&amp;lt;/b&amp;gt; - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ROS&amp;lt;/b&amp;gt; - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogenesis&amp;lt;/b&amp;gt; - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Sperm-reactive antibodies (SpAb)&amp;lt;/b&amp;gt; - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TCM&amp;lt;/b&amp;gt; - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Testicular Dysgenesis Syndrome (TDS)&amp;lt;/b&amp;gt; - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TMS&amp;lt;/b&amp;gt; - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TURED&amp;lt;/b&amp;gt; - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Varicocele&amp;lt;/b&amp;gt; - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208173</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208173"/>
		<updated>2015-10-23T02:54:59Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Structure of spermatozoa */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; .  Spermatozoa also consists of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes &amp;lt;ref name=PMID14617369&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may affect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested to have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|400px|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24714837&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few common antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
======2. Cerium dioxide nanoparticles (CNPs)======&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
======3. Vitamin E======&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
======4. Vitamin C======&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes). The following shows the simplified steps of performing ICSI, and is also outlined in the video provided. &lt;br /&gt;
*The female is administered various hormones to stimulate ovulation to release an oocyte, then the oocyte or several oocytes are removed and stored.&lt;br /&gt;
*Simultaneously, the males ejaculate is also collected and only a single spermatozoa may be required for fertilisation. &lt;br /&gt;
*Fertilisation is acheived by the directly injecting a spermatozoon into one stored oocyte using a fine needle. &lt;br /&gt;
*After 2 or 3 days, if fertilisation has successfully occured, the embryo will be transferred into the female's uterus to allow for implantation, and hopefully lead to pregnancy &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Current Research===&lt;br /&gt;
&lt;br /&gt;
The research involving male infertility most recently, is surrounding more innovative techniques to identify new and different targets to treat and diagnose the condition. A study performed in September, 2015 investigated the efficacy of using sperm chromatin structure assays to determine fertility in Nigerian men &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A total of 404 men consisting of fertile and unexplained infertile men underwent both semen analysis and sperm chromatin structure assays. Through the measurement of DNA fragmentation index, there was a more significant difference between infertile and fertile men when using sperm chromatin structure assaying &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore this new diagnostic tool may be more accurate in determining the fertility potential of males. Not only does this allow for a more predictive indicator, but it may also lead future research to use modify these technologies and perhaps find the specific molecular and cellular pathways that are affected in each individual male.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ARTs&amp;lt;/b&amp;gt; - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Aetiological factors&amp;lt;/b&amp;gt; - causative agents &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Aneuploidy&amp;lt;/b&amp;gt; - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Cadmium&amp;lt;/b&amp;gt; - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Clomiphene citrate&amp;lt;/b&amp;gt; - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;CNPs&amp;lt;/b&amp;gt; - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;FSH&amp;lt;/b&amp;gt; - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Gametogenesis&amp;lt;/b&amp;gt; - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;GnRH&amp;lt;/b&amp;gt; - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;hCG&amp;lt;/b&amp;gt; - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;hMG&amp;lt;/b&amp;gt; - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Hypogonadatropic hypogonadism&amp;lt;/b&amp;gt; - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ICSI&amp;lt;/b&amp;gt; - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;IUI&amp;lt;/b&amp;gt; - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;IVF&amp;lt;/b&amp;gt; - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Kiss1&amp;lt;/b&amp;gt; - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Klinefelter syndrome&amp;lt;/b&amp;gt; - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;LH&amp;lt;/b&amp;gt; - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Lipid peroxidation&amp;lt;/b&amp;gt; - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Progressive motility&amp;lt;/b&amp;gt; - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Quenching&amp;lt;/b&amp;gt; - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;RDA&amp;lt;/b&amp;gt; - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;ROS&amp;lt;/b&amp;gt; - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogenesis&amp;lt;/b&amp;gt; - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Sperm-reactive antibodies (SpAb)&amp;lt;/b&amp;gt; - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TCM&amp;lt;/b&amp;gt; - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Testicular Dysgenesis Syndrome (TDS)&amp;lt;/b&amp;gt; - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TMS&amp;lt;/b&amp;gt; - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;TURED&amp;lt;/b&amp;gt; - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Varicocele&amp;lt;/b&amp;gt; - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208119</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208119"/>
		<updated>2015-10-23T02:36:43Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Lifestyle Factors */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Spermatozoa also consists of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may affect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested to have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24714837&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few common antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
======2. Cerium dioxide nanoparticles (CNPs)======&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
======3. Vitamin E======&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
======4. Vitamin C======&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes). The following shows the simplified steps of performing ICSI, and is also outlined in the video provided. &lt;br /&gt;
*The female is administered various hormones to stimulate ovulation to release an oocyte, then the oocyte or several oocytes are removed and stored.&lt;br /&gt;
*Simultaneously, the males ejaculate is also collected and only a single spermatozoa may be required for fertilisation. &lt;br /&gt;
*Fertilisation is acheived by the directly injecting a spermatozoon into one stored oocyte using a fine needle. &lt;br /&gt;
*After 2 or 3 days, if fertilisation has successfully occured, the embryo will be transferred into the female's uterus to allow for implantation, and hopefully lead to pregnancy &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Current Research===&lt;br /&gt;
&lt;br /&gt;
The research involving male infertility most recently, is surrounding more innovative techniques to identify new and different targets to treat and diagnose the condition. A study performed in September, 2015 investigated the efficacy of using sperm chromatin structure assays to determine fertility in Nigerian men &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A total of 404 men consisting of fertile and unexplained infertile men underwent both semen analysis and sperm chromatin structure assays. Through the measurement of DNA fragmentation index, there was a more significant difference between infertile and fertile men when using sperm chromatin structure assaying &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore this new diagnostic tool may be more accurate in determining the fertility potential of males. Not only does this allow for a more predictive indicator, but it may also lead future research to use modify these technologies and perhaps find the specific molecular and cellular pathways that are affected in each individual male.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
ARTs - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
Aetiological factors - causative agents &lt;br /&gt;
&lt;br /&gt;
Aneuploidy - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
Cadmium - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
Clomiphene citrate - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
CNPs - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
FSH - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
Gametogenesis - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
GnRH - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
hCG - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
hMG - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
Hypogonadatropic hypogonadism - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
ICSI - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
IUI - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
IVF - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
Kiss1 - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
Klinefelter syndrome - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
LH - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
Lipid peroxidation - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
Progressive motility - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
Quenching - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
RDA - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
ROS - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
Sperm-reactive antibodies (SpAb) - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TCM - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
Testicular Dysgenesis Syndrome (TDS) - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TMS - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
TURED - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
Varicocele - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208091</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208091"/>
		<updated>2015-10-23T02:33:11Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Damage to DNA */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Spermatozoa also consists of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may affect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested to have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26157295&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24714837&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few common antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
======2. Cerium dioxide nanoparticles (CNPs)======&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
======3. Vitamin E======&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
======4. Vitamin C======&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes). The following shows the simplified steps of performing ICSI, and is also outlined in the video provided. &lt;br /&gt;
*The female is administered various hormones to stimulate ovulation to release an oocyte, then the oocyte or several oocytes are removed and stored.&lt;br /&gt;
*Simultaneously, the males ejaculate is also collected and only a single spermatozoa may be required for fertilisation. &lt;br /&gt;
*Fertilisation is acheived by the directly injecting a spermatozoon into one stored oocyte using a fine needle. &lt;br /&gt;
*After 2 or 3 days, if fertilisation has successfully occured, the embryo will be transferred into the female's uterus to allow for implantation, and hopefully lead to pregnancy &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Current Research===&lt;br /&gt;
&lt;br /&gt;
The research involving male infertility most recently, is surrounding more innovative techniques to identify new and different targets to treat and diagnose the condition. A study performed in September, 2015 investigated the efficacy of using sperm chromatin structure assays to determine fertility in Nigerian men &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A total of 404 men consisting of fertile and unexplained infertile men underwent both semen analysis and sperm chromatin structure assays. Through the measurement of DNA fragmentation index, there was a more significant difference between infertile and fertile men when using sperm chromatin structure assaying &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore this new diagnostic tool may be more accurate in determining the fertility potential of males. Not only does this allow for a more predictive indicator, but it may also lead future research to use modify these technologies and perhaps find the specific molecular and cellular pathways that are affected in each individual male.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
ARTs - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
Aetiological factors - causative agents &lt;br /&gt;
&lt;br /&gt;
Aneuploidy - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
Cadmium - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
Clomiphene citrate - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
CNPs - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
FSH - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
Gametogenesis - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
GnRH - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
hCG - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
hMG - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
Hypogonadatropic hypogonadism - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
ICSI - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
IUI - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
IVF - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
Kiss1 - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
Klinefelter syndrome - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
LH - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
Lipid peroxidation - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
Progressive motility - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
Quenching - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
RDA - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
ROS - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
Sperm-reactive antibodies (SpAb) - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TCM - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
Testicular Dysgenesis Syndrome (TDS) - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TMS - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
TURED - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
Varicocele - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208077</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=208077"/>
		<updated>2015-10-23T02:30:43Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Major Causes of Male Infertility */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Spermatozoa also consists of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may affect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested to have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24714837&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few common antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
======2. Cerium dioxide nanoparticles (CNPs)======&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
======3. Vitamin E======&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
======4. Vitamin C======&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes). The following shows the simplified steps of performing ICSI, and is also outlined in the video provided. &lt;br /&gt;
*The female is administered various hormones to stimulate ovulation to release an oocyte, then the oocyte or several oocytes are removed and stored.&lt;br /&gt;
*Simultaneously, the males ejaculate is also collected and only a single spermatozoa may be required for fertilisation. &lt;br /&gt;
*Fertilisation is acheived by the directly injecting a spermatozoon into one stored oocyte using a fine needle. &lt;br /&gt;
*After 2 or 3 days, if fertilisation has successfully occured, the embryo will be transferred into the female's uterus to allow for implantation, and hopefully lead to pregnancy &amp;lt;ref name=PMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Current Research===&lt;br /&gt;
&lt;br /&gt;
The research involving male infertility most recently, is surrounding more innovative techniques to identify new and different targets to treat and diagnose the condition. A study performed in September, 2015 investigated the efficacy of using sperm chromatin structure assays to determine fertility in Nigerian men &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A total of 404 men consisting of fertile and unexplained infertile men underwent both semen analysis and sperm chromatin structure assays. Through the measurement of DNA fragmentation index, there was a more significant difference between infertile and fertile men when using sperm chromatin structure assaying &amp;lt;ref name=PMID26473109&amp;gt;&amp;lt;pubmed&amp;gt;26473109&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore this new diagnostic tool may be more accurate in determining the fertility potential of males. Not only does this allow for a more predictive indicator, but it may also lead future research to use modify these technologies and perhaps find the specific molecular and cellular pathways that are affected in each individual male.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
ARTs - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
Aetiological factors - causative agents &lt;br /&gt;
&lt;br /&gt;
Aneuploidy - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
Cadmium - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
Clomiphene citrate - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
CNPs - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
FSH - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
Gametogenesis - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
GnRH - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
hCG - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
hMG - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
Hypogonadatropic hypogonadism - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
ICSI - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
IUI - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
IVF - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
Kiss1 - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
Klinefelter syndrome - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
LH - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
Lipid peroxidation - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
Progressive motility - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
Quenching - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
RDA - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
ROS - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
Sperm-reactive antibodies (SpAb) - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TCM - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
Testicular Dysgenesis Syndrome (TDS) - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TMS - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
TURED - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
Varicocele - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Varicocele_induced_cytoplasmic_apoptosis.jpg&amp;diff=208069</id>
		<title>File:Varicocele induced cytoplasmic apoptosis.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Varicocele_induced_cytoplasmic_apoptosis.jpg&amp;diff=208069"/>
		<updated>2015-10-23T02:28:58Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Varicocele induced cytoplasmic apoptosis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Varicocele induced cytoplasmic apoptosis==&lt;br /&gt;
&lt;br /&gt;
Energy dependent pathways in intact and varicocelized testes; Under normal conditions, glucose (GLU) is transferred the germinal cells via different GLU transporters, which supply enough energy for vital activities of cells such as germinal cell division. In contrast, lack of appropriate sources of energy forces the cells to switch energy sources from GLU to lipids. In order to use lipids the cells need adequate energy to synthesize essential enzymes such as lipase. In varicocele-induced animals synthesis of the lipase enzyme is down-regulated over time. Thus, the cells miss their ability to use the lipids as a secondary source of energy, which leads to remarkable reduction in cell division and continuation of vital functions. The induced impairments trigger cytoplasmic level apoptosis independent of the Fas pathway. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt; 26246871&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Mazdak Razi, Hassan Malekinejad '''Varicocele-Induced Infertility in Animal Models'''. Int J Fertil Steril: 2013, 9(2);141-9&lt;br /&gt;
&lt;br /&gt;
PMID  26246871&lt;br /&gt;
&lt;br /&gt;
===Copyright===&lt;br /&gt;
Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited&lt;br /&gt;
&lt;br /&gt;
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=207903</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=207903"/>
		<updated>2015-10-23T01:14:14Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:25, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=207901</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=207901"/>
		<updated>2015-10-23T01:13:50Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 6 October 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:13, 23 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=207777</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=207777"/>
		<updated>2015-10-22T22:18:03Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Spermatozoa also consist of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may effect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
=====2. Cerium dioxide nanoparticles (CNPs)=====&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
=====3. Vitamin E=====&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
=====4. Vitamin C=====&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
IUI Treatment Procedure &amp;lt;ref&amp;gt;Indira IVF. (2014, July 27) What is IUI treatment for Pregnancy. Retrieved from https://www.youtube.com/watch?v=ENrx7o_z9Ng&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
Theoretically, all that is required for in vitro fertilisation is to combine the contents of a woman’s fallopian tubes and sperm, followed by re-inserting this mixture into the uterus. In practice, however, this process would be an oversimplification and not particularly successful. There are several major steps in the procedure that are necessary for pregnancy. The first step is hyperstimulation of the ovaries. The purpose of this step is to produce several oocytes to make sure there are enough suitable candidates for the procedure. This is achieved by injecting a GnRH antagonist and gonadotropins into the female. Careful monitoring of the concentrations of these hormones is essential for the safety and well-being of the patient and for the successful removal of adequate follicles &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Next, after the follicles have reached an appropriate level of development, final maturation induction is performed, typically by injection of hCG and GnRH agonist. This step is to replace the natural surge of LH that would normally mature the ovarian follicles.&lt;br /&gt;
&lt;br /&gt;
Once the follicles have matured, they are retrieved from the ovaries by a process known as transvaginal oocyte retrieval &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This involves a needle guided by ultra-sound to pierce the vaginal walls, reaching the ovaries and finally aspiration of the mature oocytes and follicular fluid. Typically, 10-30 oocytes are removed under general anaesthesia &amp;lt;ref =namePMID26473112&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The oocytes are then inspected and only those with the highest chance of successful pregnancy are chosen and the surrounding layer of cells is removed from the eggs. Semen is washed simultaneously by removing any seminal fluid and other proteins. &lt;br /&gt;
&lt;br /&gt;
The next step is for the oocytes and semen to undergo co-incubation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26460690&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The sperm cells and oocytes are incubated in culture media at a ratio of 75 000:1. It is at this point that another ART may be used (ICSI) if the sperm count or motility is not optimal. Once fertilisation takes place, the egg is placed in special growth medium and left for approximately 2 days until the cell mass is around 6-8 cells.&lt;br /&gt;
Following this the best 2-3 embryos are selected based on a morphokinetic scoring system to increase the chances of a successful pregnancy &amp;lt;ref name=PMID22820320&amp;gt;&amp;lt;pubmed&amp;gt;22820320&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Characteristics tested include the if the growth of the cells is even, the number of cells and the level of fragmentation. &lt;br /&gt;
&lt;br /&gt;
The best embryos are transferred to the patient with a plastic catheter to the uterus. More than one may be transferred to increase the chances of a successful pregnancy in older women or women who have infertility issues. &lt;br /&gt;
In order to ensure the embryo grows normally and implants properly, the patient is given adjunctive medication. This involves injection of specific concentrations of progesterone and GnRH agonists which is performed to support the corpus luteum.&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
ICSI is typically performed during the co-incubation stage of IVF to make sure an oocyte is properly fertilised if the sperm is immobile &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473111&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
The process involves several devices under a microscope, namely; micromanipulator, microinjectors and micropipettes), and is fully outlined below:&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
ICSI Procedure &amp;lt;ref&amp;gt;Mothercare Hosp. (2014, July 7) 3D Animation of how ICSI works. Retrieved from https://www.youtube.com/watch?v=h7uucZ7xpYs&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. One of the most relevant clinical implications of ICSI is the ability to produce a viable embryo from an immature oocyte and a single spermatozoon injection; particularly due to the high proportion (15-20%) of oocytes retrieved when immature. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26473112&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
ARTs - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
Aetiological factors - causative agents &lt;br /&gt;
&lt;br /&gt;
Aneuploidy - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
Cadmium - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
Clomiphene citrate - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
CNPs - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
FSH - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
Gametogenesis - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
GnRH - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
hCG - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
hMG - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
Hypogonadatropic hypogonadism - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
ICSI - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
IUI - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
IVF - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
Kiss1 - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
Klinefelter syndrome - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
LH - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
Lipid peroxidation - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
Progressive motility - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
Quenching - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
RDA - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
ROS - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
Sperm-reactive antibodies (SpAb) - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TCM - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
Testicular Dysgenesis Syndrome (TDS) - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TMS - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
TURED - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
Varicocele - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=207559</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=207559"/>
		<updated>2015-10-22T10:47:31Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. It is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male. &lt;br /&gt;
&lt;br /&gt;
Due to the growing issue, this page will discuss the most common causes, diagnostic tools, and treatments of male infertility, and ultimately provide a scope of the topic to allow for further research to improve our current understanding of what infertility entails. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Spermatogenesis and Fertility==&lt;br /&gt;
[[File:Structure of mouse spermatozoa.jpeg|600px|thumb|Spermatozoon which is made up of two main regions, the head and the tail. ]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for its transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Spermatozoa also consist of a flagellum for progressive motility during its movement through the epididymal ducts and within the female reproductive organ.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|left|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
Although infertility refers to the inability to conceive, there are numerous disorders that address particular reasons as to why this is the case. For males, the causes of infertility are endless and the most common factors have been discussed previously. Due to the range of aetiological factors, each one may effect a different aspect of the male's sperm including sperm count, morphology and motility rates. &lt;br /&gt;
A fertile male is suggested have normospermia &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC4156950&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; , in which the male's ejaculate contains normal sperm quality and quantity which are (based on the World Health Organisation (WHO)):&lt;br /&gt;
*Ejaculate volume of approximately 1.5 to 5 mL &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Count of approximately 15 million to over 200 million spermatozoa per mL of ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Progressive motility of 32% or more spermatozoa &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Normal morphology present in 4% of the ejaculate &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;, in which normal form refers to the spermatozoa containing the 3 fundamental parts; a head, midpiece and tail. &lt;br /&gt;
&lt;br /&gt;
Based on WHO's normal semen analysis, the specific types of male infertility disorders have been categorised accordingly. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count of less than 15 million sperm/mL of ejaculate &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;23757979&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen with a progressive motility of less than 20% &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| More than 95% of spermatozoa in the ejaculate has abnormal morphology &amp;lt;ref name=Escobar&amp;gt;Escobar, J. (2013). New Semen Analysis Parameters - WHO - World Health Organization. Fertility Center in Irving and Arlington. Retrieved 20 October 2015, from http://ivfmd.net/new-world-health-semen-analysis-parameters/&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia) (referring to the statistics mentioned for each condition)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa, despite normal spermatogenesis within the semen due to a blockage in the genital tract, obstructing the pathway for sperm to enter the penis from the testes &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583161&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to the abnormal process or failure of spermatogenesis occurring, whereby sperm producing cells being damaged or destroyed &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;PMC3583162&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=QdIl1TjUvIQ&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Male Infertility &amp;lt;ref&amp;gt;Healthguru. (2008, January 4) Male Infertility (Getting Pregnant #3). Retrieved from https://www.youtube.com/watch?v=QdIl1TjUvIQ &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|left| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
* No dilationed instrascrotal veins&lt;br /&gt;
* Reflux in spermatic veins of the inguinal region during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
* No major dilation in supine position &lt;br /&gt;
* Dilated veins up to lower pole of testis seen only in standing position &lt;br /&gt;
* Reflux at lower pole veins during Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
* Dilated veins&lt;br /&gt;
* Reflex without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
 [[File:Color Doppler ultrasonography of varicocele.jpeg|300px|thumb|left|Color Doppler ultrasonography of varicocele. Maximal venous diameters in the pampiniform plexus were measured during resting (A) and during a Valsalva maneuver (B) in the standing position.]]&lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Doppler Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.   An ultrasound machine that has a Doppler mode can see blood reverse direction in a varicocele with a Valsalva, increasing the sensitivity of the examination. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  It allows the identification of minimal ectasia of the scrotal veins and minimal retrograde venous flow. Ultrasonography and particularly Colour DopplerUltrasound appear to be the most reliable and practical methods for diagnosing subclinical varicocele.  Colour Doppler Ultrasound can be used to measure the size of the pampiniform plexus and blood flow parameters of the spermatic vein. However, the reliability of the Colour Doppler Ultrasound to diagnose varicoceles remains controversial; the diagnostic criteria remain poorly defined, with considerable variation between investigators and researchers. Reflux is an important criterion for the diagnosis of varicocele. The change in color is subjective and unreliable for the diagnosis of reflux in the Colour Doppler Ultrasound examination and should be quantified with spectral Doppler analysis.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25685302&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
If sufferers addressed the above risk factors, this would allow for safe and effective prevention of male infertility as a whole, or prevent the condition from getting worse. &lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
[[File:Development of Gonadotropin Preparations.jpeg|300px|thumb|right|Development of Gonadotropin Preparations]]&lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The associated image demonstrates the development and availability of gonadotropins for commercial use.  &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The following are a few antioxidants that have been proven to treat oxidative stress, and hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
=====1. Carotenoids===== &lt;br /&gt;
*Naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Subtypes are divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Main source of carotenoids in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. &lt;br /&gt;
*Have been suggested as daily supplements for the human body, and act as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Their antioxidant activity of is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|left|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
Two common carotenoids that have been strongly advised as treatments for male infertility include lycopenes and Astaxanthin, described below. &lt;br /&gt;
&lt;br /&gt;
======Lycopenes====== &lt;br /&gt;
*Type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon.  &lt;br /&gt;
*Possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Have a role in neutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Inhibit lipid peroxidation allowing for spermatozoal membranes to be retained and protected from further damage. &lt;br /&gt;
*Suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
======Astaxanthin======&lt;br /&gt;
*Keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. it has been &lt;br /&gt;
*Suggested as an effective treatment and supplement for male factor infertility due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine. &lt;br /&gt;
*An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for increased motility concentration, improved sperm morphology and motility, and a decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
=====2. Cerium dioxide nanoparticles (CNPs)=====&lt;br /&gt;
*Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility.&lt;br /&gt;
*They are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
=====3. Vitamin E=====&lt;br /&gt;
*A fat – soluble antioxidant that exists in 8 chemical forms of different biological activity.&lt;br /&gt;
*The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;, found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. &lt;br /&gt;
*From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
=====4. Vitamin C=====&lt;br /&gt;
*A water-soluble antioxidant that neutralizes free radicals and also prevents ROS synthesis&amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
*The human body does not produce or store vitamin C, so daily intakes of vitamin C – containing foods are required to maintain its levels internally.The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
*Foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  &lt;br /&gt;
*A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocelectomy====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=3crlbOiCO48&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Varicocelectomy | Testicular Diseases | Male Infertility | Urinary Problems | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=3crlbOiCO48 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
[[File:Midline Prostatic Cyst in Ejaculatory Duct Obstruction.jpeg|300px|thumb|right|Midline Prostatic Cyst in Ejaculatory Duct Obstruction]]&lt;br /&gt;
&lt;br /&gt;
Ejaculatory duct obstruction is a rare cause for infertile men. It is usually found in cases of severe oligospermia and azoospermia indicated by a low ejaculate volume and pH, and little or no fructose in seminal plasma &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. To correct this in the minority of infertility patients, transurethral resection of ejaculatory ducts (TURED) can be performed. Firstly, a digital rectal exam will show a midline cystic lesion or dilated ejaculatory duct. The duct is instilled with methylene blue dye to open the duct and confirm the resection is in the system &amp;lt;ref name=Schroeder&amp;gt;Schroeder-Printzen, I. (2000). Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. Human Reproduction, 15(6), 1364-1368. http://dx.doi.org/10.1093/humrep/15.6.1364&amp;lt;/ref&amp;gt;. A study by Yurdakul, Gokce, Kilic and Piskin, concluded that 11 out of 12 azoospermic males with complete ejaculatory duct obstruction who received TURED had sperm in their ejaculation &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17899434&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. The following video demonstrates some common techniques that have been used to successfully retrieve sperm. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=c_nK2ZS_Mr0&amp;lt;/html5media&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Sperm Retrieval Procedures &amp;lt;ref&amp;gt;Manipal Hospitals. (2015, May 19) Sperm Retrieval IVF | Male Infertility | Infertility Treatment | Manipal Hospitals. Retrieved from https://www.youtube.com/watch?v=c_nK2ZS_Mr0 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
Intrauterine insemination (IUI) is a simple procedure performed by a medical practitioner where washed sperm is injected directly into the uterus with a catheter. This allows the sperm to get as close to the egg as possible, increasing the chances of reaching it. This method is known as in vivo fertilisation as it is performed within the body of the female. &lt;br /&gt;
It has been shown that if the woman rests for up to 15 minutes after insemination the chance of pregnancy is greater than if they are mobilised immediately after the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;19875843&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The optimal conditions for an IUI include; the female being less than age 30, the male having a total motile sperm count of more than 5 million per mL. A likely pregnancy will result from a cycle that produces two eggs of 16 mm or more and an oestrogen concentration of 500 pg/mL at the time of the procedure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18996517&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Glossary==&lt;br /&gt;
&lt;br /&gt;
ARTs - Assisted Reproductive Technologies&lt;br /&gt;
&lt;br /&gt;
Aetiological factors - causative agents &lt;br /&gt;
&lt;br /&gt;
Aneuploidy - the presence of an abnormal number of chromosomes in a cell&lt;br /&gt;
&lt;br /&gt;
Cadmium - a soft, insoluble transition metal that is a byproduct of zinc production  &lt;br /&gt;
&lt;br /&gt;
Clomiphene citrate - a non-steroidal medication that induces infertility by increasing the release of GnRH, LH and FSH required for spermatogenesis&lt;br /&gt;
&lt;br /&gt;
CNPs - Cerium dioxide nanoparticles&lt;br /&gt;
&lt;br /&gt;
FSH - Follicle stimulating hormone&lt;br /&gt;
&lt;br /&gt;
Gametogenesis - a biological process resulting in the formation of mature haploid male (spermatogenesis) and female (oogenesis) germ cells &lt;br /&gt;
&lt;br /&gt;
GnRH - Gonadotropin releasing hormone&lt;br /&gt;
&lt;br /&gt;
hCG - Human chorionic gonadotropin&lt;br /&gt;
&lt;br /&gt;
hMG - Human menopausal gonadotropin&lt;br /&gt;
&lt;br /&gt;
Hypogonadatropic hypogonadism - a condition characterised by a decrease in functional activity of the gonadH&lt;br /&gt;
&lt;br /&gt;
ICSI - Intracytoplasmic Sperm Injection&lt;br /&gt;
&lt;br /&gt;
IUI - Intrauterine Insemination&lt;br /&gt;
&lt;br /&gt;
IVF - In Vitro Fertilisation&lt;br /&gt;
&lt;br /&gt;
Kiss1 - KiSS-1 Metastasis-Suppressor; a gene that codes for Kisspeptin, a G protein coupled receptor associated with hypogonadotropic hypogonadism &lt;br /&gt;
&lt;br /&gt;
Klinefelter syndrome - genetic disorder whereby a male has an extra X chromosome &lt;br /&gt;
&lt;br /&gt;
LH - Luteinizing hormone&lt;br /&gt;
&lt;br /&gt;
Lipid peroxidation - the oxidation of lipids causing its degradation, usually caused by ROS &lt;br /&gt;
&lt;br /&gt;
Progressive motility - the swimming of sperm from one place to another rather than in circles or twitching &lt;br /&gt;
&lt;br /&gt;
Quenching - the deactivation of reactive oxygen forms  &lt;br /&gt;
&lt;br /&gt;
RDA - Recommended dietary allowance&lt;br /&gt;
&lt;br /&gt;
ROS - Reactive oxygen species&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis - the production of development of new sperm &lt;br /&gt;
&lt;br /&gt;
Sperm-reactive antibodies (SpAb) - antibodies present on the membrane of spermatozoa that result in adverse affects to reproduction and often infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;8194608&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TCM - Traditional Chinese medicine&lt;br /&gt;
&lt;br /&gt;
Testicular Dysgenesis Syndrome (TDS) - a syndrome resultant of the disruption of embryonal programming and gonadal development during fetal life that is related to poor semen quality and testicular cancer, &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11331648 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
TMS - Total Motile Sperm&lt;br /&gt;
&lt;br /&gt;
TURED - Transurethral resection of ejaculatory ducts&lt;br /&gt;
&lt;br /&gt;
Varicocele - Abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205613</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205613"/>
		<updated>2015-10-15T11:27:30Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
'''Group 5'''&lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205611</id>
		<title>Talk:2015 Group Project 5</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_5&amp;diff=205611"/>
		<updated>2015-10-15T11:27:03Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Peer Review= */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
Hey guys - i tried to upload a video for the how cancer cells work section  - but i have no idea how to do it, tried looking it up but have failed immensely! so i you know how to do it - please explain haha so grateful! thanks --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 12:42, 4 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:23, 25 September 2015 (AEST) OK, there is so much more that should be on your project page by now. That currently consists of all text, no media, histology, graphics, tables etc. Furthermore no discussion of animal models used in research for this topic. This project page is not ready for peer review.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone,&lt;br /&gt;
the page is coming together well. &lt;br /&gt;
only thing is while we write up our parts can we focus on all using in text referencing so that we are consistent and can just have a single reference list at the bottom.&lt;br /&gt;
I found out how to use the same reference again and only have it associated with one in text number, so if you are using the same reference and would like me to show you how to do this let me know :)&lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 21:40, 14 September 2015 (AEST)&lt;br /&gt;
 &lt;br /&gt;
I have added some of the references + citations but not yet finished as this is only the draft and I might delete some of the parts so there is no point adding the citations/ text referencing now. I will add my part at the end. I'm still waiting for your part to see what to do. http://www.ncbi.nlm.nih.gov/pubmed/15951668&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:35, 17 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
=Research/Review articles=&lt;br /&gt;
&lt;br /&gt;
===[Oncofertility and breast cancer: Where have we come from, where are we going?].===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25991386&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article focuses on the current context of national and international recommendations, techniques development to evaluate and preserve fertility and patients' claims, this study aims to make a survey about the management of patients' breast cancer regarding oncofertility. This article concludes that , in order to satisfy patients' requests, several improvements have to be made regarding the patients' information, the health professionals' awareness and care coordination.I don't go through it now but very interesting article to read and useful for our group project.&lt;br /&gt;
&lt;br /&gt;
===Emergency fertility preservation for female patients with cancer: clinical perspectives.===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26026071&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about clinical perspectives to explore the new as well as the currently available options and strategies that can be used for emergency fertility preservation of female cancer patients.Such options include emergency ovarian stimulation, embryo freezing, egg freezing, ovarian tissue freezing and autotransplantation, in vitro maturation, and ovarian protection techniques. This article also mentions the advantages and disadvantages of each option as well as a new comprehensive multi-step strategy for these situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Sexual dysfunction and infertility as late effects of cancer treatment===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26217165&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
As all we know, Sexual dysfunction is the main consequence of cancer treatment. Problems are usually linked to damage to nerves, blood vessels, and hormones that underlie normal sexual function. This article emphasizes on these sexual dysfunction and does in depth. It addresses that innovations in cancer treatment such as robotic surgery or more targeted radiation therapy have not had the anticipated result of reducing sexual dysfunction. Therefore, advances in both technologies and in knowledge about how cancer treatments can damage fertility, offer hope to patients who want children.&lt;br /&gt;
&lt;br /&gt;
===Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26264701&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This article explains about psychological outcomes in female cancer patients who undergo fertility preservation counseling/consultation (FPC), with or without fertility preservation (FP).I read through the whole article as I found it really interesting and relevant to our group project. This is another subheadings we can add to those.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 11:24, 24 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I DID THE SAME :) &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Variability in the practice of fertility preservation for patients with cancer.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26010087&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This is an interesting article on how reproductive endocrinologists counselled cancer patients on fertility preservation. This is relevant to our group projects because it gives us an idea of what techniques and services are currently being utilised to help women. &lt;br /&gt;
&lt;br /&gt;
===Strategies for fertility preservation in young patients with cancer: a comprehensive approach.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24669162&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article recognises that as cancer treatment improves the life span of patients, with it comes the treat to fertility. It is a great article as it clearly states what methods are currently available for addressing fertility preservation in males and females. &lt;br /&gt;
&lt;br /&gt;
===Clinical guide to fertility preservation in hematopoietic cell transplant recipients.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24419521&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article focuses specifically on patients suffering infertility due to hematopoietic cell transplantation. It lists the options available to the patients whether female or male, which are applicable to patients who underwent other treatments and also lists the barriers to fertility preservation.&lt;br /&gt;
&lt;br /&gt;
===Fertility preservation in patients with haematological disorders: a retrospective cohort study.===&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24140311&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This article addresses fertility treatment in patients with haematological disorders specifically. However, is it a really good article as it is a cohort study comparing patients at various stages in their cancer journey, such as those who have had prior chemotherapy, those who pursued ovarian stimulation and those who did not pursue fertility treatment at all.&lt;br /&gt;
&lt;br /&gt;
just moving my articles here for reference while i edit the project page. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 11:39, 14 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
Hi&lt;br /&gt;
I have added some points to the page but i will add more info soon. In terms of references and accurate citation, I have written down all the references and I will add those at the end as I might edit/delete some of them. I will explain those fertility drugs too. just added the names and do them over weekend.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:58, 11 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi everyone, &lt;br /&gt;
&lt;br /&gt;
yes, I agree we have to assign everyone a certain section to write about, I'm happy to do Infertility causing cancers ( I already found those related articles from pubmed) and Oncofertility timeline. so if everyone is happy I can start it :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3463890|Z3463890]] ([[User talk:Z3463890|talk]]) 08:05, 27 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hi People, &lt;br /&gt;
&lt;br /&gt;
Does anyone know how to reference a non pubmed source? I'm not sure how to reference the general information that we want to put on our page? &lt;br /&gt;
I definitely think also that we should assign everyone a certain section to cover - so that were not all just editing and adding stuff in chaos - Ive started editing the chemotherapy section of the page - i hope this is alright if i take that on- i found some good info! dont worry the stuff i have up now is no where near finished.. just having a play around with general stuff and trying to get the hang of editing etc... (literally no nothing about IT...) But at the end it obviously will be all sorted and good :) &lt;br /&gt;
&lt;br /&gt;
Thanks&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 16:18, 26 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey everyone, &lt;br /&gt;
&lt;br /&gt;
As discussed we will be researching oncofertility as our topic for this week, and depending on how successful our research is we will decide on whether we stick to the topic or not. &lt;br /&gt;
I have added some potential subheadings to help guide our research, feel free to change them and add more. &lt;br /&gt;
We need to pick a subheading each and find research articles related to it for this weeks individual lab assessment. &lt;br /&gt;
https://oncofertility.northwestern.edu/patients/fertility-preservation-options-nu --&amp;gt; this is a good website to trigger ideas to research. &lt;br /&gt;
--[[User:Z3463667|Z3463667]] ([[User talk:Z3463667|talk]]) 17:12, 23 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
==Peer Review===&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
Let me start off by commending this group on a fantastic page! It is incredibly thorough, detailed and long. You can immediately see that a lot of work and research has gone into it. You have a great list of references and they appear to be cited correctly throughout the page. However, some sections which appear to be incomplete and lack some citations e.g. “fertility preservation”. &lt;br /&gt;
&lt;br /&gt;
One suggestion I will make, is it would be good to see the addition of some hand-drawn images, perhaps one under either of the first 3 headings. Some more images could be used under the heading “surgery”. The videos used on this page are great. Really informative, relevant and easy to watch. I also think the “what are cancer cells” section should be higher up on the page as it is part of the basis of what the whole page is about. It also cuts between the two sections “chemotherapy” and “how does chemotherapy work?” which should be one after another. On the topic of formatting, you have a heading in there called “oncofertility timeline”, I think it would be better placed at the beginning of the page where it is more relevant. &lt;br /&gt;
&lt;br /&gt;
I also think there is just too much text in some areas e.g.  “Fertility preservation in women” and “surgery”. It makes that part of the page look clustered and difficult to read. Perhaps simplifying it more into bullet points, as you have done in other areas of the page, would be good. Conversely though, I think areas such as “targeted drugs” and “bone marrow or stem cells transplant” could use more work, however, it is possible you still intend to work on those areas anyway. &lt;br /&gt;
&lt;br /&gt;
I would suggest adding a glossary to the bottom of your page to assist in those who view your page with a lower level of scientific knowledge. You have covered an expansive range of topics pertaining to your topic, all of which are relevant and link well with each other. The page has a great focus on the learning aims of embryology. I think with some formatting corrections and some simplification of the text, this will be a really wonderful page.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
Awesome page so far guys! I commend you on your use of various videos to assist in conveying your ideas. Furthermore, the images you have chosen are highly relevant to the topic of discussion and assist the reader in gaining a greater understanding of oncofertility. All copyright information is present for the images you have used which is excellent to see.&lt;br /&gt;
It may be worth including a hand drawn image under the 'radiation' subheading, as we are required to include at least one such image. The current image under the radiation subheading could easily be replicated by hand and could fulfill this portion of the criteria.&lt;br /&gt;
&lt;br /&gt;
I am nitpicking here, but I would also recommend including some kind of media, most likely a picture, underneath the surgery subheading. It might even be worth doing the hand drawn image here if possible. A picture may also be good underneath the 'types of chemotherapy drugs' subheading, just to break up the wall of text and improve the reading experience for the reader.&lt;br /&gt;
It might also be worth restructuring the 'oncofertility limitations' subheading into the form of a table (if possible), as the bullet point format feels quite awkward and out of place compared to the rest of the page.&lt;br /&gt;
The inclusion of a glossary is also recommended, as this page will be accessible by the general public and a glossary will assist those without a background in embryology to understand and appreciate your content.&lt;br /&gt;
&lt;br /&gt;
Keep up the great work guys! Your page is absolutely amazing so far and the effort you have put in is definitely reflected in the high quality of your page.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===3===&lt;br /&gt;
&lt;br /&gt;
'''COMMENDATIONS'''&lt;br /&gt;
&lt;br /&gt;
•	The short video was a good visual aid that helped me understand your topic. &lt;br /&gt;
 &lt;br /&gt;
•	The use of tables and a few images were good additions to your page. &lt;br /&gt;
&lt;br /&gt;
•	Good referencing throughout.&lt;br /&gt;
&lt;br /&gt;
•	Your “Oncofertility Timeline” was great; straight to the point and well organised. Maybe place it at the beginning of your page as a part of your introduction? &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''RECOMMENDATIONS'''&lt;br /&gt;
&lt;br /&gt;
•	Make sure your proofread your work; I saw a few very long sentences that could be broken up into smaller sentences. This will make your page easier to read and understand.&lt;br /&gt;
&lt;br /&gt;
•	Furthermore, some words are capitalised that don’t need to be; e.g. “Oncofertility” in your introduction and “Chemotherapy” in the Infertility section. &lt;br /&gt;
&lt;br /&gt;
•	Your page would benefit from the use of subheadings. There are large chunks of information under your headings, making it a bit difficult to follow at times (particularly in your Radiation section). &lt;br /&gt;
&lt;br /&gt;
•	I recommend reading through your information and removing details that may be excessive. By making your information more concise, your page will flow better and will encourage the audience to keep reading. Some of the information is a bit repetitive across your sections.&lt;br /&gt;
  &lt;br /&gt;
•	I liked the use of a table in “Fertility Preservation in Men,” however, I feel as though you could add more details to it. I found the concepts presented in this table difficult to understand; maybe link it a bit better to the information below? Or just organise all of the information into a table?&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Very well researched topic, with all key points being addressed. Condensing all of your research and being a little more selective about what you include will be the key to a great final page.&lt;br /&gt;
&lt;br /&gt;
===4===&lt;br /&gt;
&lt;br /&gt;
The wikipage looks like it’s progressing very well, especially with the amount of content and references I can safely say you guys have worked hard on it and have done a substantial amount of research so well done guys. I liked the flow chart that you guys inserted, it really simplified the understanding of the IVF procedure as opposed to reading lengthy text. I also particularly liked the collapsible timeline which was presented very nicely and summarised the progress of oncofertility over time very well. &lt;br /&gt;
&lt;br /&gt;
As for improvements, the references definitely need to be fixed up. There were multiple appearances of the same reference and some of the links also did not work such as reference 24 and 25. On top of that the referencing for the websites were not in a consistent format and some were also done incorrectly so be sure to fix that up. I would also look out for the type of sources used such as webmd and medianews today. I’m not entirely sure if they are reliable or acceptable but I suggest you consult Mark about that. &lt;br /&gt;
&lt;br /&gt;
Additionally, the use of tables is a very good way of presenting information however, for the tables under the topic of fertility preservation for both men and women I initially though that each of the columns was a comparison against each other. Only later did I realise that each of the columns contained an individual list of treatments. To minimise the confusion I suggest rearranging the table and labelling row 1 as ‘Before treatment’, then row 2 as ‘During treatment’ and finally row 3 as ‘After treatment’ then collectively placing the treatments in their rightful spaces in the following column. &lt;br /&gt;
&lt;br /&gt;
A glossary is also missing from this page, having the definitions of the more difficult terms would assist with understanding the topic. Also on another note in the ‘Types of Chemotherapy drugs’ section, I think it would look more aesthetically pleasing if bullet points were used rather than the dashes. &lt;br /&gt;
&lt;br /&gt;
Overall, there is a substantial amount of content, and great use of images, videos and tables. Keep up the good work! &lt;br /&gt;
&lt;br /&gt;
===5===&lt;br /&gt;
&lt;br /&gt;
This page is progressing really well. You have lots of content aided by some videos and relevant images. You have discussed extremely relevant aspects of your chosen topic, which is highly commendable, however the page seems very content heavy. I would suggest making the bolded headings as actual subheadings to make it easier for the reader to ‘jump’ sections. This is evident for sections “Surgery”, “Fertility Drugs”, and “Fertility Preservation in Men and Women”. To break up the text further and keep the page exciting for your audience, consider using bullet points to convey your information under the sections previously mentioned. You have used dashes (-) but perhaps the different colour and layout of the bullet points will make your page much neater. &lt;br /&gt;
I should also note that the oncofertility timeline has been condensed well. You may want to move it to the top of the page for readers to understand the history of oncofertility and its progression. &lt;br /&gt;
&lt;br /&gt;
The videos you have incorporated are very insightful and easy to understand. The same can be said for the images on the page as they help to explain the information you have laid out. The only exception I have is for the images under “Radiation” and “Chemotherapy”. Although they are relevant and simple, you may want to replace them for a diagram or flow chart that is more practical to the reader. For example, you could draw a diagram or flow chart of how radiation and chemotherapy eliminate cancer cells. Because you have a lot of text, try adding more images, videos, or condensing the information into a table, especially in “Surgery”, “Types of Chemotherapy Drugs” and “Fertility Preservation”. &lt;br /&gt;
&lt;br /&gt;
Throughout the page, there are areas that have not been focused on as much as others. This includes “Artificial Insemination” and “In-Vitro Fertilisation” where there is very little content. These processes are currently really big in the fertility industry so with more research, I am certain there will be relevant articles to use for your page. You could also refer to these studies specifically to support the content, and discuss their success rates. &lt;br /&gt;
&lt;br /&gt;
The references have been cited inconsistently, which can be fixed with proofreading. In particular, references 19 to 25, 33 and 44 needs to be checked as they have been incorrectly cited or are non-existent. I am also finding that content under a few sections are lacking in-text references, such as “Radiation”, “How Does Chemotherapy Work?”, “Types of Chemotherapy Drugs” and “Side Effects”. Be sure to add citations in these headings to avoid being accused of plagiarism, and to encourage further reading by your readers. &lt;br /&gt;
&lt;br /&gt;
So far this page is very impressive. The amount of information you have included, and the useful videos shown, demonstrates your hard work and efforts into making this page successful. With more editing, visual aids and content, this page will be tremendous. Well done!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===6===&lt;br /&gt;
&lt;br /&gt;
This is an excellent group project wiki. The content covers the topic in all aspects. However, there might be excessive effort in the investigation of ‘infertility’, ’Fertility Drugs’ and ‘Chemotherapy’, which occupied more than half of your project page. They are relevant to this topic, but might need to be consolidated to balance the page.&lt;br /&gt;
&lt;br /&gt;
Images and videos are good choice in your page. It would be better if more images, diagrams, tables are added into your page to balance the texts.&lt;br /&gt;
&lt;br /&gt;
Referencing and citing are excellent in most section, although some sections seem to be lack of in-text references. You might still want to work on them.&lt;br /&gt;
Overall, this wiki is an excellent work in investigating oncofertility. It is relevant to the aim of learning embryology.&lt;br /&gt;
&lt;br /&gt;
===7=== &lt;br /&gt;
&lt;br /&gt;
Awesome page overall guys- I think everyone has agreed that it is an amazing achievement and you have done a great job. &lt;br /&gt;
&lt;br /&gt;
The amount of research and the number of resources; as well as the correctly referenced sources, is something the be very proud of. It also presents a very thorough and detailed explanation about the topic that creates a well rounded and highly informative page. I also really liked the inclusion of bolded subheadings under the &amp;quot;Surgery&amp;quot; section as it made the page easier to read; however there seems to be a little bit of inconsistency as later in the page seemingly random words are in bold text- I wasn't sure of their importance or whether you were going to include a glossary so I got a little side tracked and I found that section a bit more difficult to read. &lt;br /&gt;
&lt;br /&gt;
A few areas of improvement-- there aren't many; especially to do with the actual writing and information of this page. The first would be to include some more images, videos, tables or diagrams. Although you have quite a few already, the sheer size of the page and the amounts of information beneath each subheading means that you really do need to have more interactive elements and visual aids to help with understanding the content; I found that sometimes I got a little lost within the large chunks or writing and it became more difficult to follow. There seems to be a little bit of inconsistency throughout the page and because there are such vast amounts of information beneath most subheadings,  I think that it would be beneficial to restructure some of the sub headings such as &amp;quot;Bone marrow or stem cell transplants&amp;quot; into sub-sub-headings to aid with continuity and over all visual aesthetics of the page. Finally, another way to reduce to presence of chunks of information would be to utilise some more tables to break up the volume and density of information, especially because it is a very heavy (terminology wise) topic. &lt;br /&gt;
&lt;br /&gt;
Over all you guys have done an absolutely outstanding job and I really look forward to the final product!! Good Luck!!&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205603</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205603"/>
		<updated>2015-10-15T11:04:18Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
'''Group 3'''&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!   &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_3&amp;diff=205601</id>
		<title>Talk:2015 Group Project 3</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_3&amp;diff=205601"/>
		<updated>2015-10-15T11:03:49Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Peer Asssessment */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:19, 25 September 2015 (AEST) OK so this is far from ready for peer assessment. This is a very large topic with many possible sub-headings (missing from your project page) as well as animal models and environmental/genetic information. I cannot see any illustrations, images, media, resources added to the project page to illustrate the topic and give a balance to the content.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 02:07, 27 September 2015 (AEST) Hey guys, where do you think we should include animal models? Also I think it'd be a pretty snazzy idea to have a cartoon/photograph of polycystic ovaries in the intro and then for causes/pathogenesis have a flow chart or something similar&lt;br /&gt;
&lt;br /&gt;
----[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 16:20, 27 September 2015 (AEST) Hey guys, I've found some pretty snazzy images of polycystic ovaries, but do you know if we have to find the copy right information to be able to use the images? Most of the images come from google-image linked sites and don't really give much information on usage&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3459224|Z3459224]] ([[User talk:Z3459224|talk]]) 14:40, 29 September 2015 (AEST) Yeah I'm pretty sure we have to find the copy right information for all our images. I think it would be best if we try to find images on Pubmed first. If not we can use other journal databases. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 16:51, 30 September 2015 (AEST) Agreed, I'll get rid of the one I put up as I couldn't really find any copyright information for it. I'll have another browse of pubmed and see what I can find&lt;br /&gt;
&lt;br /&gt;
----[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 17:35, 30 September 2015 (AEST) I uploaded a new image/flowchart with some proper referencing. I'm thinking that my discussion of pathogenesis will largely be on insulin resistance and hyperandrogenemia&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3459224|Z3459224]] ([[User talk:Z3459224|talk]]) 12:24, 2 October 2015 (AEST) That sounds good! If you need any articles, let me know. I came across a few articles on pathogenesis. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3416054|Z3416054]] ([[User talk:Z3416054|talk]]) 14:03, 6 October 2015 (AEDT) Howdy guys! I added an image of some polycysts present on the polycystic ovaries of a rat. It's nothing too amazing, but if you think it's not necessary/appropriate for the section let me know and I can find another pic&lt;br /&gt;
'''Sub-headings'''&lt;br /&gt;
]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Peer Asssessment==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
&lt;br /&gt;
I'm a little confused as to what your actual topic is? Is it female infertility or polycystic ovarian syndrome? I think it is important to clarify that so as the reader of your page continues reading, they know the exact topic they are reading about.  I also think that where you have written “definition” under the big picture of the PCOS ovaries, it should say “epidemiology” as that is more what it sounds like. I also think the picture should be below the information, that way we know a bit better what we’re looking at. &lt;br /&gt;
&lt;br /&gt;
I love the little purple box of information under the “Definition” as it stands out and is pleasing to the eye. The purple boxes throughout the page are really great! The image next to it is also really good as it is clear and relates back to the information beside it. Great use of images! They are all relevant and placed well and the hand drawn image is done well. Your “pathogenesis” section is great as are your sections “diagnosis” and “prevention and treatment”. Detailed and easy to read. It was great to see scientific and animal models throughout the page. Perhaps it would be good to include a little more information linking directly to the literature for more advanced readers. I would also suggest adding a glossary to the bottom of your page, as for people with little to no scientific background who may read this, they may not understand all the words and terms.&lt;br /&gt;
&lt;br /&gt;
It appears under the subheading “environmental factors” that there is no referencing? However, aside from that you have an extensive references list and have referenced correctly and thoroughly throughout the page. I would also suggest adding a bit more information under the heading “causes” aside for the subheading “genetics” as the other sections look a bit bare. The layout is great, easy to read and follow however one suggestion may be to get rid of the underline below your subheadings. It just may make things look a little less clustered and final. &lt;br /&gt;
&lt;br /&gt;
You seem to have covered all the key points pertaining to your topic, however, a section on complications of either PCOS or female infertility may be good to add. Your content and headings are good and references are cited properly. I would suggest perhaps relating it back a bit more to the basics of embryology and discuss what a pregnancy would be a life is a woman with PCOS did get pregnant. Overall, this is a really great page with a good layout that flows well. Keep up the good work!&lt;br /&gt;
&lt;br /&gt;
===2===&lt;br /&gt;
This project page is nicely organized, and well balanced with graphs, tables, and diagrams. It is wise to narrow down the topic and focus on the female infertility caused by polycystic Ovarian Syndrome. But it will be better if the other possible causes are mentioned at the beginning.&lt;br /&gt;
&lt;br /&gt;
The image ‘ PCOS Ovary vs. Non-PCOS Ovary’ explains the differences between normal and PCOS Ovary very well. It will be better if the image is inserted after the texts which define PCOS as it causes confusion about your topic at the current location.&lt;br /&gt;
&lt;br /&gt;
The use of colour highlighting is very impressive. It do make the important messages stand out. &lt;br /&gt;
&lt;br /&gt;
This Page has correct referencing. Current scientific researches are nicely summarized and fitted into the context. It is impressive to include animal and cell culture models in the pathogenesis section.&lt;br /&gt;
&lt;br /&gt;
Overall, the wiki page has covered the topic well. Contents are concise and easy to understand. It would be better if a ‘glossary’ can be added to explain some of the terminologies for readers.&lt;br /&gt;
&lt;br /&gt;
===3===&lt;br /&gt;
&lt;br /&gt;
First and foremost the PCOS Ovary Vs Non-PCOS Ovary hand drawn image is amazing and its placement at the beginning really drew in my attention to the topic. I also particularly liked the purple theme set up throughout the wikipage, I thought it really helped bring the page together.The headings, subheadings and images are all set out neatly making it very presentable and easy to follow. The language used was also very engaging which is always a plus. Content wise there seems to be sufficient information under most of the headings which really showed your efforts and elaborate research on the topic. The only portion that wasn’t particularly well present was the environmental factors. I felt like it needs the inclusion of some examples. &lt;br /&gt;
&lt;br /&gt;
To improve your page I would like to suggest the addition of a glossary that you could use to briefly define some terms such as ‘Hirsutism’ to allow a better understanding of the text. Additionally, I also noticed that under the ‘Hyperandrogenemia’ heading there was the use of the acronyms ‘GnRH’ and ‘LH’. Be sure to express the full term placing the acronym in brackets upon their first appearance before extensive use. I saw that this was done in the following paragraph where LH was initially correctly expressed as Luteinising Hormone but again this should be done at its very first appearance. The page also lacked some history surrounding the origin of the disease and how some of the treatments were established so that could also be included. &lt;br /&gt;
&lt;br /&gt;
Overall, the presentation of the page gave me the impression of a good understanding of the topic so well done guys! Keep up the good work.&lt;br /&gt;
&lt;br /&gt;
===4===&lt;br /&gt;
&lt;br /&gt;
Really good introduction! It clearly outlines what is in the page and it serves to summarise the topic and highlight the areas that you will be addressing. It includes in-text citations and I’d like to acknowledge the hand drawn diagram and the efforts taken to do that. Great job.  However, it is a bit pixelated so maybe try resizing the image to a smaller size. &lt;br /&gt;
&lt;br /&gt;
This project was done really well. All key points, i.e. “causes”, “Pathogenesis”, “Signs and Symptoms” and etc., were clearly described. In terms of content, this group did a great job. It is very informative and all information they have included are relevant to the topic. There is a great deal of information that is presented in a strong manner with the use of adequate images, tables and diagrams. Images and diagrams can help summaries what some of the paragraphs communicate. For the” Prevention and Treatment”, your table is fantastic as it is informative, concise and relevant to the topic. Use of tables is always beneficial as it makes the page more inviting. Otherwise the page appears to overwhelming with just written content and no visual content to reinforce concepts and information. This was the case for previous groups so well done on that. There is an extensive list of references, which demonstrates, a great effort towards researching your projects system. Only for one of the references which is not from PubMed, you need to put into in the correct format and add the exact date you visited the website.&lt;br /&gt;
&lt;br /&gt;
On the down side, there is an inconsistency in the amount of information throughout the page. Some sections lack information more than others for example you need more information for “Environmental Factors “and “Medications”. Thus, this can be a room for improvement to insure further research is done in those sections. I believe, this is a very large topic with many possible sub-headings so try to come up with more sub-heading. Yes, you mentioned animal models and environmental/genetic information but you need to do more research as these sections must be in more depth and more explanations. Most of the sections have great amount of detail with a number of in text citations and this is great to see. However I do notice that there is no videos what so ever, not sure if you are having trouble finding, or if you have left this until the last thing. Consider some youtube videos. This could help balance the amount of text you have, making the page more interesting. The project could also benefit from having a ‘Glossary’ list so that viewers can understand some uncommon words. A glossary list should be incorporated in a separate subheading. If you are having a plan to add more information to the page, splitting it into bullet points from now on might be a better way of organising it so peers get a more effective learning experience when they read it.&lt;br /&gt;
&lt;br /&gt;
Overall, this is a good project page, well done group and best of wishes!!&lt;br /&gt;
&lt;br /&gt;
===5===&lt;br /&gt;
Currently, this Wikipage is very impressive through the incorporation of numerous images, and tables. Because this page is mainly focused on PCOS I feel as though you should either remove “Female Infertility” from the title of the page or at least give an overview of other factors that may cause female infertility in the introduction. &lt;br /&gt;
&lt;br /&gt;
The amount of images that have been used in this project page is highly commendable. The hand drawn image in particular, is very simple and clearly demonstrates the morphology of PCOS in comparison to a normal ovary. You have used a variety of diagrams to show various aspects of PCOS thus making the page very intriguing to the reader. Perhaps you could use videos or gifs to further explain diagnostic tools and pathogenesis of the disease. &lt;br /&gt;
&lt;br /&gt;
I am also finding that there are inconsistencies throughout each section of the page. For example, under “Causes” there is a lot of information about genetic factors in comparison to the one line explaining that there are environmental aspects associated with PCOS. Perhaps you could look more into this aetiological factor and “Obesity and Diet” and refer to specific studies that prove this.  Again for “Medication”, consider listing a few examples that are known to be an associated risk for PCOS. Also when discussing signs and symptoms of PCOS, you mentioned infertility. Since you stated in the introduction that PCOS is the most common cause of infertility, you should expand more on this mechanism and why it does this. &lt;br /&gt;
&lt;br /&gt;
The layout of the tables and colour scheme is consistent, making it appealing to the reader. However for the “Current Treatments” table, consider adding another column to address the advantages of each. Success rates are provided but further explanation on their benefits would be great. Grouping prevention and current treatments together, it seems as though you forgot to add preventative measures in an obvious way. A few sentences on this should be enough to clearly state this. Also consider putting a glossary as you have used terms such as 'hirsutism', and mentioned hormones GH and LH without initially writing their full names. &lt;br /&gt;
&lt;br /&gt;
Your group has shown extensive research and correct citations for each reference. As a reader of your page, I suggest that more of your research should focus on specific studies to support the content and on topics that are lacking important information such as “New Trials”, “Current Treatments” and “Causes”. &lt;br /&gt;
&lt;br /&gt;
This page has a very good framework and structure. Adding more content, relevant pictures and references will ensure a great final page.&lt;br /&gt;
&lt;br /&gt;
===6===&lt;br /&gt;
&lt;br /&gt;
The progress you have made on your project so far is exceptional. Your key points are clearly taught at a peer level and your choice of headings, diagrams and tables so far has been well thought out. I especially commend you on a great drawing in the top of your page. It is drawn clearly and is a great depiction of the uterus and ovaries from the outside and inside and of Polycystic Ovarian Syndrome. Your introduction and epidemiology is beautifully complemented with the map you have included and the addition of a coloured box to highlight the definition of PCOS as the focus.  &lt;br /&gt;
&lt;br /&gt;
It is evident you have conducted wide and extensive significant research that also goes beyond the teaching aspect. This is clear through your inclusion of specific studies, explanation of animal models and cell culture models used in PCOS and the thorough description of your key points due to your extensive research. Well done on using all pubmed articles except for one!&lt;br /&gt;
&lt;br /&gt;
Some suggestions on editing your work would be to briefly mention the cysts in your definition for PCOS since it is a main element of PCOS as depicted in your drawn image at the beginning of your page. The environmental factors are too vague, you could elaborate on this by including examples of environmental factors or explaining why the constant gene pool would indicate environmental factors in the aetiology of PCOS. You could also consider adding an advantages column to your treatment table if it is relevant. Also, while you have provided a great overview of PCOS, maybe also consider adding brief descriptions of other causes of infertility in women since it is your topic area with a focus on PCOS. &lt;br /&gt;
&lt;br /&gt;
Some minor adjustments to make are to remember to add the retrieval date to the website you have used in reference 6. Also, you should increase the size of the map under the definition heading so that the percentages are readable and the country locations more visible and the flow chart under hyperinsulinemia so that it is clearer and the words are more readable by increasing the resolution of your files. The project is coming along great, your thorough effort into the project is evident.&lt;br /&gt;
&lt;br /&gt;
===7===&lt;br /&gt;
&lt;br /&gt;
As a first impression, this page is remarkable and provides a very thorough description, explanation and presentation of facts about PCOS. I really like the first image as it immediately caught my eye and demonstrated the differences between an affected ovary and a normal ovary in an easy to understand way. Furthermore the information under the &amp;quot;definition&amp;quot; section was very interesting, however I think maybe re-naming this would be more beneficial because at first I was a little confused about the topic, whether it was focusing more on female infertility or PCOS as a cause of infertility. &lt;br /&gt;
&lt;br /&gt;
Other strengths of this page were the clear and well thought out lay out that allowed easy movement through the page and a logical progression of subheadings. Lastly, the &amp;quot;Pathogenesis&amp;quot; section is exceptionally researched and the range of resources you used highlights the extent and detail of your research- something that you all should be very proud of. &lt;br /&gt;
&lt;br /&gt;
Some areas of improvement include providing more in depth information on some of the sub-headings in the &amp;quot;causes&amp;quot; section including environmental factors, obesity and diet and medication. More information on these areas would really aid in providing a thorough explanation and furthering the readers understanding of the topic. The inclusion of some more visual aids such as a video and maybe even some images or graphs/tabels in the &amp;quot;causes&amp;quot; section to break up the bulk of text. Finally, the inclusion of a glossary at the end of the page would be very useful- especially when considering this page is forwards-facing and can be accessed by the public; some sentences and paragraphs are very dense and use a lot of jargon and terminology that could be further defined in a glossary. &lt;br /&gt;
&lt;br /&gt;
On a light note to end, the little touches such as the bold text throughout the paragraphs highlighting important words and key concepts, as well as the recurrence of the purple colour throughout the page really brought the wiki together and contributed to the flow and overall aesthetic of the page. Overall, you guys have done an awesome job!! Good luck with your final edits!!&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205587</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205587"/>
		<updated>2015-10-15T10:23:05Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
'''Group 2'''&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_2&amp;diff=205585</id>
		<title>Talk:2015 Group Project 2</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_2&amp;diff=205585"/>
		<updated>2015-10-15T10:22:33Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Peer Review */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5016784|Z5016784]] ([[User talk:Z5016784|talk]]) 14:42, 13 October 2015 (AEDT) Just regarding the peer reviewing of other group projects, do we have to be assessing all 5 other projects?&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:16, 25 September 2015 (AEST) Hmm still a little thin. There should be some animal model info, histology images, physiological data, drug info, and genetic information.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 17:15, 18 August 2015 (AEST) Hello there&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 16:12, 24 August 2015 (AEST) Hey guys! So I've gone and added a few subheadings that may be useful to start researching. For this weeks assessment we need to choose one each and find 3 articles to go with it etc. So if we all choose one and start researching it, that would be good :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 11:02, 26 August 2015 (AEST) Good article for treatment http://humupd.oxfordjournals.org/content/16/5/459.abstract?etoc&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 19:20, 26 August 2015 (AEST) Sweet, Thanks for putting up those headings to get things going. Lets all put up related documents by Thursday so we have can discuss things at the Lab this Friday!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 19:29, 26 August 2015 (AEST) I've put up some interesting pubmed documents on our main page, Have a read through them (I haven't read them all yet)&lt;br /&gt;
&lt;br /&gt;
=== &amp;lt;span style=&amp;quot;font-size:75%&amp;quot;&amp;gt;'''Classifications of Ovarian Hyper-stimulation Syndrome'''&amp;lt;/span&amp;gt; ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Classification'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;650px&amp;quot;| '''Symptoms'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Mild''' &lt;br /&gt;
|style=&amp;quot;height: 75px; background: #CCEEEE;&amp;quot;| '''Grade 1''' - Abdominal distention and discomfort&lt;br /&gt;
'''Grade 2''' - Abdominal distention, discomfort with nausea, vomiting and/or diarrhea and ovarian enlargement from 5~12cm&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Moderate'''&lt;br /&gt;
|style=&amp;quot;height: 75px; background: #EEEEEE;&amp;quot;| '''Grade 3''' - All features of Mild OHSS with ultrasonographic evidence of ascites&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Severe''' &lt;br /&gt;
|style=&amp;quot;height: 75px; background: #CCEEEE;&amp;quot;| '''Grade 4''' - All features of Moderate OHSS with the addition of clinical evidence of ascites and breathing difficulties present&lt;br /&gt;
'''Grade 5''' - All of the above symptoms along with a change in the blood volume, increased blood viscosity due to coagulation and diminished renal function&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 11:40, 28 August 2015 (AEST) I wont be able to make it to uni today for the lab and the meetup after it. Got to take my cousin to the ER&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 12:07, 28 August 2015 (AEST) I was thinking to include the risk factors in the 'causative' subheading&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 13:22, 28 August 2015 (AEST) So basically in the Causative subheading, I was planning&lt;br /&gt;
1) Identify the different causes (including primary and secondary risk factors)&lt;br /&gt;
2) What difference occurs from a normal cycle (e.g. level of hCG normally)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 13:36, 28 August 2015 (AEST) No problem! I hope your cousin is okay. Whoever added a sub heading called: Tests and Diagnosis, there already is the same kind of subheading, Symptoms and Diagnosis so we need to merge the two. It also needs to be in chronological order&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3372824|Z3372824]] ([[User talk:Z3372824|talk]]) 13:46, 28 August 2015 (AEST)Hope he gets well! Talking about sections, I'll try and work on Prevention, and get the research summaries done for that section by next week.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3372824|Z3372824]] ([[User talk:Z3372824|talk]]) 14:00, 28 August 2015 (AEST) J and I had a little discussion about how we're going to go about completing this. We can all work on each others sections and collaborate that way. Let's focus on finding research articles, collating them, referencing them i.e. get to the meat of the matter. Once we've done that we can cut to the point and make it more easy-to-read/user-friendly. We also think that our 1 wiki page reference should be the OHSS Wiki page. Also, when writing about your section, always compare/refer to the Controlled Ovarian Stimulation case. Bring those picture/youtube suggestions in!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3374116|Z3374116]] ([[User talk:Z3374116|talk]]) 00:12, 29 August 2015 (AEST) Sweet, thanks for the info. Will be on the lookout for youtube clips and pictures. Is the OHSS wikipage you are referring to https://en.wikipedia.org/wiki/Ovarian_hyperstimulation_syndrome&lt;br /&gt;
this one?? And I agree on helping each other with respective sections and then cutting it down to the fine details&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 21:49, 1 September 2015 (AEST) Yes, that's the wiki page :) I have already started taking down information from it in each section so when you see '''[OHSS Wiki]''', that's where the information is from. I just don't know how to reference something that is not pubmed yet haha&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 22:11, 1 September 2015 (AEST) Also guys please note, I have not used any info. from wiki in regards to TREATMENT and PREVENTION as it appears someone is already working on those subheadings and I don't want to interfere, so yea, that info. is still out there for you guys to use.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3415911|Z3415911]] ([[User talk:Z3415911|talk]]) 11:51, 13 September 2015 (AEST) Hey guys, can everyone please send me an email with your full names so I can add you on fb and make  group. I feel like we need a better way of communicating. Thanks, z3415911@student.unsw.edu.au.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z5016784|Z5016784]] ([[User talk:Z5016784|talk]]) 16:25, 13 October 2015 (AEDT) Hey guys, i am working on a few sections, mark said not to add to the project until the peer assessments are done, so i was thinking of bringing my information to class on Friday so yous can have a look and see if it is useful enough, i will place the link to one article, it has two tables in there that i think can be used, what are your thoughts about them?&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842872/&lt;br /&gt;
&lt;br /&gt;
Video that J found!&lt;br /&gt;
http://www.howcast.com/videos/511910-ovarian-hyperstimulation-syndrome-infertility/&lt;br /&gt;
&lt;br /&gt;
==Peer Review==&lt;br /&gt;
&lt;br /&gt;
This wikipage is very well put together. Your choice of headings, subheadings and tables and images is remarkable, it definitely makes the whole page flow very well. I particularly like the hand-drawn image which does a great job at simplifying the process of the pathogenesis of OHSS. &lt;br /&gt;
&lt;br /&gt;
The introduction very concisely explains the contents of the page and I liked how it was finished off with a statement about the aim of the page. I thought it really brought the introduction together nicely. I can’t say much about the content except that it is very engaging and very well written so well done guys! Keep up the good work!&lt;br /&gt;
&lt;br /&gt;
Some suggestions I have that could improve your page include adding more images. It would be nice to have some graphs to complement the statistical date from the epidemiology. Also, in some of the paragraphs e.g. in the last paragraph of ‘Epidemiology’ there isn’t a citation that accounts for the information at the end of the paragraph so that should be fixed. &lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
This page clearly and efficiently explains the topic of choice. It covers all relevant matters well and the text is descriptive and informative. After reading the page, I felt as though I had a greater understanding of the topic. The subheadings used are good, and are placed appropriately in order - providing an element of cohesiveness between the page and the topic in general. Good use of linking statements – connecting all the elements discussed on the page. &lt;br /&gt;
&lt;br /&gt;
There is however an excessive amount of text used. Although the information is relevant and informative, the page is dense and reading all at once is tiresome. Reducing/sifting through the amount of text on the page – and also adding a great deal more media files will help to break up the denseness of the page. There is only 1 image on the whole page – greater attention needs to be paid to alternative media files and sources to help break up the page. Additional media files will also add to increasing the understanding of readers. &lt;br /&gt;
	The diagram drawn is neat and cited correctly. --[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 15:07, 13 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
This Wiki covers the topic well. The content is very well written and easy to understand.  Images and texts are correctly cited and referenced. In some of the sections, eg, ‘Ovulation Induction’, ‘Avoiding hCG during Luteal Phase Support’, more in-text reference will need to be added.&lt;br /&gt;
&lt;br /&gt;
It is a great idea to have some bold texts in lines, which highlight the main points of paragraphs, and help readers to understand when skimming.&lt;br /&gt;
&lt;br /&gt;
The hand-draw diagram of ‘pathogenesis of OHSS’ is excellent. It is well structured, and easy to understand and memorize.  It will be great if more images, diagrams, videos can be added to the other sections.&lt;br /&gt;
&lt;br /&gt;
Overall, the project page is very well developed. Some of the sections need to have more work on though. It would be nice if more graphs and tables can be added to balance the texts.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
So far your wiki page gives a very good coverage of Ovarian Hyper-Stimulation Syndrome. The progression of your subheadings progresses logically from one topic to another. It's good to see that you've included an excellent hand-drawn image which is well suited to the 'pathophysiology' subheading. The amount of textual information you have under each heading is vast and gives a comprehensive description of OHSS. Furthermore, you have an excellent range of sources to support your discussion.&lt;br /&gt;
&lt;br /&gt;
I feel however that asides from your hand-drawn image, your use of images and other source of media is definitely lacking. As is, your page is largely text with little to no breaks, making it quite difficult to read. The use of images would not only help break up the monotony of the text, but also help reinforce some of your ideas. I feel that the inclusion of images in the 'symptoms' and 'complications' subheadings would be suitable. &lt;br /&gt;
&lt;br /&gt;
It may also be worthwhile to include subheadings concerning current research, to inform readers about contemporary developments regarding OHSS. Furthermore,  'future research' could also be another potential subheading and could illuminate potential areas that are beginning to be or could be investigated in coming years.&lt;br /&gt;
&lt;br /&gt;
Overall, a very impressive page so far, that could be enhanced with the addition of relevant images and other media.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
Great work, it looks like your group has a clear mindset and direction to where your group project is going, even if it is not there yet. Also great introduction! Your entire page's contents were introduced well and simple. However, all Text and no images were included except one image. Not a good look to go through. The information here is good but is also very dense and hard to follow without any images. It would be great if you could break it up a bit with more images, tables, diagrams and hand drawn pictures. This style of writing is very professional and would be perfect for a report or essay; however as a wiki page it is too hard to follow. Breaking up the information into tables and short videos would allow you to guide the reader through your topic.  Well done on the use of bullet points make it easy to follow. Only one hand drawn image as well as one table uploaded onto the page contains adequate information explaining them, which is good. &lt;br /&gt;
&lt;br /&gt;
Well done on use of “Glossary” section. It is indeed necessary and important. &lt;br /&gt;
&lt;br /&gt;
There has clearly been a lot of research and work put into this project and that is very commendable and I do appreciate it. However on a whole as I mentioned, there is too much information without having any interactive techniques such as tables, diagrams and etc. One of my suggestions is to make a table for “Prevention” or “Genetics” section or even both. I also suggest adding another subheading for “current research findings” or “Future research” which requires more time and research. Therefore you can include more journal articles in this section .In this section pictures would also be good to help understand and engage readers. Overall,  well done on your written information for each section. They’re very relevant to the topic and to the project as well.&lt;br /&gt;
&lt;br /&gt;
Some sections like “Effect on the Newborn” or “Animal Models” seem to be untouched. I’m assuming you are still in the process of adding content. Please be aware of the deadline. Moreover, in text citation is crucial which are missing in some paragraphs. Citations should be carried through the entire page to know exactly where you have got your information from. Good job on referencing at the end of the page. All research articles seem to be relevant to all sections.&lt;br /&gt;
&lt;br /&gt;
Overall, it is a really good project with the potential to be excellent because of the amount of effort you have put into the research. Keep up the good work, but just edit and add those things I mentioned to the project and finish the sections you need to. Very well done so far and good luck with finishing the project off.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
I found your topic very intriguing! It appears as though you have put a lot of time into researching your area and ensuring that your have addressed the main concepts. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''COMMENDATIONS'''&lt;br /&gt;
&lt;br /&gt;
•	Fantastic introduction! It gave me a clear overview of what your group’s topic is, and it was easy to understand. &lt;br /&gt;
&lt;br /&gt;
•	Great overview of the symptoms. Your table added some colour to the page and the information was succinct. &lt;br /&gt;
&lt;br /&gt;
•	You are to be commended on your hand drawn image - very clear and neat. Good job! &lt;br /&gt;
&lt;br /&gt;
•	Clear reference list and good in text citations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''RECOMMENDATIONS'''&lt;br /&gt;
&lt;br /&gt;
•	A map in the Epidemiology section would put your text into perspective for the reader. &lt;br /&gt;
&lt;br /&gt;
•	Some words have been typed in bold (particularly in the Diagnosis section). The selected words seem to be a bit random. Maybe you could highlight phrases rather than words, or organise the information under subheadings. &lt;br /&gt;
&lt;br /&gt;
•	More images would break up the information and aid the reader’s understanding of the given concepts. Subheadings would also help organise the information to place ease on reading and comprehension. &lt;br /&gt;
&lt;br /&gt;
•	Your page features large chunks of text for the most part. I would recommend reading through your text and removing excessive bits of information; try and be a bit more succinct. You could use more tables and diagrams to communicate certain concepts as well (e.g. Treatment and Diagnosis). &lt;br /&gt;
&lt;br /&gt;
•	Information is absent under “Animal Models” and “Effect on the Newborn.”&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
With this said, your group has covered all the key concepts and it is evident that you have done a lot of in depth research. You are definitely on the right track. &lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
Collectively, this page is well structured and shows you have a well-rounded understanding of this topic. The introduction encapsulates the whole topic extremely well and provides a good framework for the rest of the page. The headings are relevant and follow the structure to discuss a disease, thus being very easy for the reader to grasp the key concepts of the syndrome. Perhaps consider using bullet points in your “Causative Agents” section and “Prevention” heading. You can also utilize numerical steps to describe the pathogenesis of OHSS to accompany the well-structured diagram, and to break up the text in your page. &lt;br /&gt;
&lt;br /&gt;
I have also noticed that the page is lacking subheadings in a few sections, thus it prevents the reader from knowing the key points that are being discussed and explained. Together with the subheadings that are already present, they can also be used under “Diagnosis” for each diagnostic tool, “Genetics” for VEGF, LHR and BMP-15, and possibly in the “Animal Models” section. The content under each of these headings however, is very interesting and has been written well, showing you have gained a thorough understanding of OHSS. I am certain the content you add for the untouched headings will also be of a high standard. On that note, further explanation about treatments and complications of OHSS could be added. These sections are currently lists therefore they can be further expanded with more research and videos to explain things like surgery procedures. &lt;br /&gt;
&lt;br /&gt;
The glossary provided is extremely beneficial however; more diagrams, tables, and videos should be incorporated to further enhance the reader’s understanding. At the moment it is quite content heavy and needs visual aids to make the page more interesting and easy to read. &lt;br /&gt;
&lt;br /&gt;
This page also demonstrates that you have thoroughly researched each aspect of OHSS, and have used recent studies to support the content added. The resources have all been cited correctly, but perhaps search for more literature to further support your claims and theory regarding OHSS. &lt;br /&gt;
&lt;br /&gt;
I am really impressed with your page so far. Using more references, visual aids, and adjusting the format of this page will guarantee a successful mark. Well done! &lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
I’d like to start by commending you on an exceptional choice of key points which you have chosen to research and elaborate on. They provide a good overview of the subject for your readers. They are clearly explained and taught at a peer level without dragging on with irrelevant points. Your introduction is well written, I especially like that you have included the aim of you wikipage in the introduction and the key points you will be focusing on to orient your reader. Including epidemiology was also a good choice as it shows the relevance and impact of Ovarian-stimulation syndrome in society. I also find that including prevention and treatment is great for visitors without an embryology background who are looking for general information on the topic, especially for women who can learn to better reduce their risk since this page is accessible to the public. &lt;br /&gt;
&lt;br /&gt;
Other great aspects of your page include the inclusion of a glossary for readers to refer to when they are unclear on the terminology and that you have used relevant sources. The table used to organize the symptoms makes its easy to read and understand. I particularly liked your section on the pathophysiology. Not only is it explained well but you have included a great hand drawn diagram that is clearly drawn, complements the adjacent paragraphs well and includes a statement with permission to other visitors to reuse it. &lt;br /&gt;
&lt;br /&gt;
Going forward your main focus’ should be conducting further research to complete your remaining key points on the effects on the Newborn and animal models (very relevant for embryology peers). Also, focus on including more supporting diagrams and figures since so far you only have one. A histological image of the ovaries would be very appropriate to your topic. Make sure you read over your page to edit your grammar and wording for example in the phrase “they are given to assistive medication”. Your citing is well done, but make sure when you are referencing websites that you include the retrieval date such as in reference 11. &lt;br /&gt;
&lt;br /&gt;
Overall your page is well written, with my main concern being is it sounds more like a report than a peer teaching page. You can fix this by adding more images, diagrams, figures and tables to break up the text and help to explain your content. Adding a video would also be engaging. Otherwise, great progress so far! &lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
Everyone seems to have already commented on your introduction, but it will not deter me from giving you another amazing high five! That introduction is so well thought out and structured that it has set up the entire page in an easy to read and easy to understand way- amazing work!! The page as a whole was fantastically structured and I found it very easy to follow which made the experience of reading and learning about the topic. Furthermore the topic was outstandingly researched with a wide variety of sources and really demonstrated the time and effort that you guys have put into it so great job; however, one thing that lets you down here is that there are some citations missing or large chunks of writing that are not cited which is a shame because it is evident that you have put in the time and effort. The language that has been used through out the page, although very formal, was appropriate and made it easy to understand the information. This was further aided by the inclusion of the glossary which is a necessity and was very well planned. I also really enjoyed the inclusion of the section &amp;quot;Epidemiology&amp;quot; as it provided a comprehensive snap shot and scope of the disease. &lt;br /&gt;
&lt;br /&gt;
Some aspects that you could improve on include the inclusion of more images, videos, graphs and tables. Again, everyone seems to have commented on this, there is too much writing and it makes it difficult to follow and stay concentrated on the information. Another point to improve on would be further explanations about the treatment and prevention, this would be highly beneficial as it not only would provide information to students but also relevant and useful information to the public as the site is public facing. Lastly, the information missing below the “Effect on the Newborn” and “Animal Models” section will add another layer of detail and ultimately complete the page. &lt;br /&gt;
&lt;br /&gt;
Overall, you guys have done an amazing job- the main area of improvement is the inclusion of more interactive and visual elements that can break up the chunks of texts and make the page more well-rounded. Awesome work and I look forward to seeing the end result!!&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205581</id>
		<title>User:Z3462124</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3462124&amp;diff=205581"/>
		<updated>2015-10-15T10:06:21Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ANAT2341 Course Work&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 20:29, 6 August 2015 (AEST) Thanks for setting up your page. We will be talking more about this in the [[ANAT2341_Lab_1_-_Online_Assessment|Practical on Friday]].&lt;br /&gt;
&lt;br /&gt;
==Lab attendance==&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:46, 7 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 13:15, 14 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:08, 21 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:04, 28 August 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:15, 4 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:05, 18 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3462124|Z3462124]] ([[User talk:Z3462124|talk]]) 12:34, 25 September 2015 (AEST)&lt;br /&gt;
&lt;br /&gt;
{{StudentPage2015}}&lt;br /&gt;
&lt;br /&gt;
[[Test Student 2015]]&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''Assessment 1:''' Find two recent research references on fertilisation or in vitro fertilisation and write a summary of the research article method and findings. &lt;br /&gt;
&lt;br /&gt;
PMID 26285703 '''Does obesity have detrimental effects on IVF treatment outcomes?'''  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26285703&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study looked at the influence of BMI on IVF treatment outcomes, particularly those undergoing ICSI treatments. &lt;br /&gt;
&lt;br /&gt;
'''Method:'''&lt;br /&gt;
&lt;br /&gt;
Participants underwent IVF following standard procedures and embryos were transferred into the uterus at either 3 or 5 days. On day 12 of the ET, patients had B-hCG levels assessed and once exceeded 2000IU/L they underwent transvaginal ultrasounds to confirm pregnancy. A number of key parameters of the patient and the IVF-ICSI were considered and analyzed; including patient age, antral follicle count and BMI and number of retrieved oocytes, proportion of oocytes fertilized and total gonadotropin dose, respectively.  Patients were then divided into three groups based on their BMI value; normal, overweight and obese. Those classified as underweight were excluded due to the small number of patients. Finally, potential correlations between BMI, total gonadotropin use and other parameters and success of IVF-ICSI treatments were evaluated. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was found that there was a significant difference in total gonadotropin dose and stimulation duration across all weight categories. Specifically, it was demonstrated that both gonadotropin dose and stimulation duration were higher in participants classified as obese. Other findings included that rates of clinical pregnancy, spontaneous abortion and ongoing pregnancies were approximately equal across all three weight groups. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
PMID 26264981 '''Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval.''' &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26264981&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This study compared the grnaulosa cell function across three different age groups; young oocyte donors (21-29 y.o.a) middle aged oocyte donors (30-37 y.o.a) and older infertile patients (43-47 y.o.a).&lt;br /&gt;
&lt;br /&gt;
'''Methods:'''&lt;br /&gt;
&lt;br /&gt;
Total Number of Patients: 136&lt;br /&gt;
&lt;br /&gt;
Group 1: ages 21-29; 31 patients &lt;br /&gt;
&lt;br /&gt;
Group 2: ages 30-37; 64 patients &lt;br /&gt;
&lt;br /&gt;
Group 3: ages 43-47; 41 patients &lt;br /&gt;
&lt;br /&gt;
All subjects underwent controlled hyperstimulation and oocyte maturation, followed by a transvaginal ultrasound-guided oocyte retrieval. Oocyte donors were stimulated in a long gonadotropin releasing hormone agonist cycle and infertile patients were stimulated in microdose agonist cycles. Oocytes collected at retrievals were cultured and those classified as mature (presence of 1 polar body) were fertilised and further cultured in Blastocyst medium for three days. Real time PCR and western blot in the granulosa cells collected from follicular fluid were used to analyse the relationship between gene expression and gonadotropin activity, steriodogenesis, apoptosis and luteinization. &lt;br /&gt;
&lt;br /&gt;
'''Results:'''&lt;br /&gt;
&lt;br /&gt;
It was demonstrated by a down regulation of &amp;quot;FSH receptor (FSHR), aromatase (CYP19A1) and 17β-hydroxysteroid dehydrogenase (HSD17B) expression&amp;quot; and an up regulation of &amp;quot;LH receptor (LHCGR), P450scc (CYP11A1) and progesterone receptor (PGR)&amp;quot; with increasing age of patients that age related functional decline in granulosa cells were consistent with premature luteinization. Patients who received earlier retrieval to avoid premature luteinization demonstrated a marginal increase in oocyte prematurity, however, exhibited improved embryo numbers and quality as well as satisfactory clinical pregnancy rates. &lt;br /&gt;
&lt;br /&gt;
From these results, the researches concluded that earlier retrieval of oocytes can be utilised to avoid premature follicular luteinzation, which is a key contributor to the rapidly declining successful IVF results in women over 43. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:54, 4 September 2015 (AEST)These are accurate summaries of these 2 research papers. (5/5)&lt;br /&gt;
==Lab 2 Images== &lt;br /&gt;
&lt;br /&gt;
{{Uploading Images in 5 Easy Steps table}}&lt;br /&gt;
&lt;br /&gt;
[[File:Syrian Hamster In Vitro Fertilisation PMID- 24852961.jpeg|300px]]&lt;br /&gt;
&lt;br /&gt;
Syrian Hamster In Vitro Fertilisation PMID- 24852961&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24852961&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibiting+Sperm+Pyruvate+Dehydrogenase+Complex+and+Its+E3+Subunit%2C+Dihydrolipoamide+Dehydrogenase+Affects+Fertilization+in+Syrian+Hamsters]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) Image uploaded correctly with reference, copyright and student template. I have fixed the reference that had an unnecessary &amp;lt;/ref&amp;gt;. (5/5)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
Research articles associated with male infertility in humans. &lt;br /&gt;
&lt;br /&gt;
1. Aydos SE, Karadağ A, Özkan T, Altınok B, Bunsuz M, Heidargholizadeh S, Aydos K, Sunguroğlu A. '''Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility.''' PMID 26125837&lt;br /&gt;
&lt;br /&gt;
2. V. A. Giagulli, Carbone, G. De Pergola, E. Guastamacchia, F. Resta, B. Licchelli, C. Sabbà, and V. Triggiani '''Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?''' PMID 24691874&lt;br /&gt;
&lt;br /&gt;
3. Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E, Georgiou I. '''Semen quality is influenced by androgen receptor and aromatase gene &lt;br /&gt;
synergism.''' PMID 23001776&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 10:58, 4 September 2015 (AEST) These relate to your group project topic. You might have used the correct reference format (as shown below) and included a single descriptive sentence about each reference. (4/5)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26125837&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;24691874&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;23001776&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab4==&lt;br /&gt;
&lt;br /&gt;
Design 3 quiz questions based upon any of the major subjects we have covered to date. Add the quiz to your own page under Lab 4 assessment and provide a sub-sub-heading on the topic of the quiz&lt;br /&gt;
&lt;br /&gt;
'''Placental Development Quiz'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;quiz display=simple&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{Which one of the following is most correct? Primary villi are:&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
+ developed in week 2 and are the first development stage of chorionic villi, composed of trophoblastic shell cells. &lt;br /&gt;
- the first stage of chorionic villi development and cover the entire surface of the chorionic sac.&lt;br /&gt;
- composed of only syncitiotrophoblasts. &lt;br /&gt;
- developed in week 3 and form finger like extensions that are primarily located at the chorion frondosum. &lt;br /&gt;
- composed of only cytotrophoblasts. &lt;br /&gt;
||Yes, Primary villi are developed in week 2 and are the first stage of chorionic villi development. They are composed of trophoblastic shell cells (both syncitiotrophoblasts and cytotrophoblasts) forming finger like projections that extend into the maternal decidua. &lt;br /&gt;
&lt;br /&gt;
{Which of the following is the type of placenta found in humans?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Diffuse&lt;br /&gt;
- Zonary &lt;br /&gt;
+ Discoid &lt;br /&gt;
- Cotyledenary &lt;br /&gt;
- None of the above&lt;br /&gt;
||Yes, discoid is the name given to the type of placenta found in humans. It is also the type of placenta found in mice, insectivores, rabbits, rats and monkeys. &lt;br /&gt;
&lt;br /&gt;
{Which one of the following is the most common placental abnormality?&lt;br /&gt;
|type=&amp;quot;()&amp;quot;}&lt;br /&gt;
- Chronic Intervillostis; the inflammation of placental lesions.&lt;br /&gt;
- Vasa Previa; fetal vessels lie within the membranes close to or crossing the inner cervical os. &lt;br /&gt;
- Placenta Previa; villi penetrate the myometrium and cross through to the uterine serosa. &lt;br /&gt;
+ Placenta Increta; placenta attaches deep into the uterine wall, penetrating into the uterine muscle &lt;br /&gt;
- Hydatidiform mole; a placental tumour develops with no embryo development &lt;br /&gt;
||Yes, Placenta Increta is the most common form of placental abnormality, accounting for approximately 15-17% of all cases. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;/quiz&amp;gt;&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:07, 4 September 2015 (AEST) Well designed, though a few issues. Q1 not correct as second option (the first stage of chorionic villi development and cover the entire surface of the chorionic sac) is just as correct as the first. Q2 is better designed, though you might explain the other types in the answer and link to page with further information. Q3 I guess you are deliberately giving incorrect options (e.g.. Placenta Previa) here though your question suggests that these are all real possibilities. Once again, your answer does not help the student understand the topic. (7/10)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[ANAT2341 Student 2015 Quiz Questions]]&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''Cleft Lip and cleft palate are associated with many different environmental and genetic causes. Identify and describe one cause of these abnormalities.'''&lt;br /&gt;
&lt;br /&gt;
Cleft lip and Cleft palate (CLP) are one of the most common congenital birth defects in humans, occurring in approximately 1/500 to 1/1000 births worldwide. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Of these cases, approximately 70% are classified as Nonsyndromic; meaning that there is a likely relationship between both genetic factors and environmental factors. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; There is a strong evidence to support the theory that CLP is influenced more heavily by genetic factors than environmental factors with incidence being greatest is Asian populations, followed by Caucasians and finally those of African decent, even in cases occurring after migration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Cleft lip and Cleft palate can also be defined as syndromic, meaning that they have not occurred as a single, isolated event within a family and are of genetic origin. Those classified as syndromic (more than 300 different syndromic disorders) can occur following Mendelian inheritance of alleles from a genetic lovus  &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;9360903&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; or due to repetitive chromosomal rearrangements. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16942766&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; However, the emerging research on the etiology of CLP suggests that the development of these congenital birth defects are a result of the complex interactions between both environmental and genetic causes, including the exposure to chemical pollution, hazardous cigarette smoke and occupational exposure. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26343712&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 7== &lt;br /&gt;
&lt;br /&gt;
'''1.Identify and write a brief description of the findings of a recent research paper on development of one of the endocrine organs covered in today's practical.'''&lt;br /&gt;
&lt;br /&gt;
Paven K. Aujla, Vedran Bogdanovic, George T. Naratadam &amp;amp; Lori T. Raetzman. '''Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure''' Developmental Dynamics: 2015, 244;8 PMID25907274&lt;br /&gt;
&lt;br /&gt;
The pituitary gland is known to be an endocrine organ of dual ectodermal origins. Rathke's pouch and the primordium of both the anterior lobe and intermediate lobe are formed by the proliferation of cells of the oral ectoderm midline. The neurohypophysis region which forms the infundibulum and pars nervosa are of neuroectodermal origin. Pituitary development is influenced by factors such as SHH, BMP and FGF that exchange signals between the developing pituitary and hypothalamus. The Notch signalling pathway is present in both the hypothalamus and the pituitary and is responsible for the downstream of effector gene Hes1 that is essential in pituitary organogenesis. This study evaluated the contribution of the Notch signalling pathway of the hypothalamus to pituitary gland organogenesis. This was achieved through the manipulation of Notch function (loss or gain) in the developing hypothalamus of mice. &lt;br /&gt;
&lt;br /&gt;
Findings of this experiment demonstrated that a loss of effector gene Hes1 in the hypothalamus did not alter the gene expression in the posterior hypothalamus or the expression of Notch target Hes5. However, the study revealed that ectopic Hes5 and increased Hes1 expression is a direct result of increased activated Notch expression in the hypothalamus and is sufficient to disrupt pituitary development and postnatal expansion. This altering of pituitary development is a result of a disruption in the signalling pathways between the hypothalamus and the pituitary by persistant Notch expression. Therefore, it was concluded that persistent Notch signalling and Hes5 expression adversely affects pituitary development and expansion.   &lt;br /&gt;
&lt;br /&gt;
==Lab 9==&lt;br /&gt;
'''Group 1'''&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page.&lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures.&lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
PMID 26244658&lt;br /&gt;
&lt;br /&gt;
look at this&amp;lt;ref&amp;gt;&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26244658&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Here's the list&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=205579</id>
		<title>Talk:2015 Group Project 1</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2015_Group_Project_1&amp;diff=205579"/>
		<updated>2015-10-15T09:59:37Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015discussionheader}}&lt;br /&gt;
&lt;br /&gt;
==Stem cell presentation==&lt;br /&gt;
Hi, I have listed some papers which I am interested in doing because it is highly relevant to my own project. But I am more than happy if you post other papers and topics which interest you and we can work on them together and get ready earlier.&lt;br /&gt;
 &lt;br /&gt;
PMID 26295456&lt;br /&gt;
&lt;br /&gt;
PMID 26439174&lt;br /&gt;
&lt;br /&gt;
PMID 24837661&lt;br /&gt;
&lt;br /&gt;
PMID 26418893&lt;br /&gt;
&lt;br /&gt;
'''PMID 24981862'''&lt;br /&gt;
&lt;br /&gt;
Hey, my pick would be C. Sturgeon et al. Wnt Signaling. purely on ease of doing a review. PMID 24837661. If that suites people. --[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 15:51, 12 October 2015 (AEDT)&lt;br /&gt;
==Useful resources==&lt;br /&gt;
&lt;br /&gt;
Here is a good source for overview and status of 3 Person IVF. http://www.geneticsandsociety.org/article.php?id=6527&lt;br /&gt;
&lt;br /&gt;
==Mitochondria==&lt;br /&gt;
*discovered in muscle by Kölliker in 1857&lt;br /&gt;
*mitochondria are the &amp;quot;powerhouses&amp;quot; of the cell and the location where respiration occurs at the cellular level.&lt;br /&gt;
*mitochondria contain their own DNA (mitochondrial DNA or mtDNA) that has been originally inherited only from the oocyte (maternal inheritance).&lt;br /&gt;
*The spermatozoa (paternal) mitochondria- energy for fertilization motility but are generally destroyed during the first mitotic cell divisions. &lt;br /&gt;
*This pattern of inheritance has important implications for a variety of mitochondrial associated diseases, usually occurring in tissues requiring lots of energy (muscle, brain). &lt;br /&gt;
&lt;br /&gt;
[[File:Mitochondria EM01.jpg|200px|thumb|Electron micrograph of mitochondria.]]&lt;br /&gt;
&lt;br /&gt;
===Eukaryotic mitochondrial genomes===&lt;br /&gt;
*double stranded circular DNA (mitoDNA. mtDNA)&lt;br /&gt;
*1981 complete human sequence (16,569 nucleotides)&lt;br /&gt;
**37 genes&lt;br /&gt;
**encodes 13 polypeptides involved in oxidative phosphorylation&lt;br /&gt;
*remaining genes transfer RNA (tRNA) and ribosomal RNA (rRNA)&lt;br /&gt;
*multiple copies within the matrix&lt;br /&gt;
*maternally inherited&lt;br /&gt;
*remainder encoded by nuclear DNA&lt;br /&gt;
*proteins made in cytosol and imported into mitochondria&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
link to Embryology website  [[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==Chat==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 11:13, 25 September 2015 (AEST) OK so just text on your page to date and not yet a thorough coverage of the topic. Animal models, timeline, images, diseases.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z8600021|Mark Hill]] ([[User talk:Z8600021|talk]]) 16:07, 21 August 2015 (AEST) I think you will have 3 students and therefore will exist as a group.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 17:29, 21 August 2015 (AEST) hi all,sorry that I still could not make my way to uni today due to illness. I will definitely be back next week. I have added few sub-headings to the points you guys setup, feel free to change them. BTW, would you like to pick one of the 5 topics for now? and start working on it? or there was some good arrangement already? please let me know.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3292373|Z3292373]] ([[User talk:Z3292373|talk]]) 20:51, 24 August 2015 (AEST) Hey, ummm sorry i lead us astray putting up those headings ''female fertility'' had been taken so we have to pick another. I put up the list of ones left. My choice would be three parent ivf. So ill do a bit of research and on that now (add some headings)just 'cuase i got some free time, but by all means if you guys would like to do something else that interests you I'm more then happy to change. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3251292|Z3251292]] ([[User talk:Z3251292|talk]]) 13:19, 27 August 2015 (AEST) Hi all, I am good with your choice. let's work on 3 person embryo. i have added few papers I find good on this topic.&lt;br /&gt;
&lt;br /&gt;
===General===&lt;br /&gt;
&lt;br /&gt;
Note to self doing history benifits.&lt;br /&gt;
&lt;br /&gt;
===Section===&lt;br /&gt;
&lt;br /&gt;
==Peer Reviews==&lt;br /&gt;
&lt;br /&gt;
===1===&lt;br /&gt;
This wiki page does well in covering a lot of areas relating to the topic, however the website does not outline the information found/used quite clear enough or to the right extent. The page would benefit largely in focusing much more attention to the mechanics of the process itself and how it physically works. There is lots of information regarding other various aspects relating to the topic, however the fundamentals of the topic are not clearly discussed on the page, and it is not clear what goes on in the process. &lt;br /&gt;
&lt;br /&gt;
The page should also fix up some grammatical and syntax errors. Read through the page carefully and ensure all paragraphs make sense ensuring that the quality of the information portrayed is fully appreciated. To also make the page clearer, some thought should be given to rethinking the order of the subheadings. Having a natural cohesion throughout the page as a whole is important – some subheadings do not fit into place correctly and could be moved around a little bit. Also having linking sentences within paragraphs – involving each subheading with others and the topic as a whole – will  make the page much more cohesive. &lt;br /&gt;
&lt;br /&gt;
The page used a good amount of supporting pubmed articles, hwoever more images/media files could be used to break up the concentrated use of text. The video used is relevant and informative – however there is no copyright information.--[[User:Z5015534|Z5015534]] ([[User talk:Z5015534|talk]]) 22:44, 10 October 2015 (AEDT)&lt;br /&gt;
&lt;br /&gt;
===2===&lt;br /&gt;
Hi guys! I'll start of by saying that the images and video you have included are excellent and are relevant to your topic of discussion. Also, you have a large number of reliable references which is good to see. However you have yet to include a hand drawn image, which is required for the wiki page. I feel like  you could probably eliminate the typed out 'timeline of mitochondrial donation' and instead use this as an opportunity to use a hand drawn image of the timeline. Furthermore, the timeline under 'cystoplasmic transfer' feels a bit awkward and unnecessary. You could probably include this timeline alongside the 'timeline of mitochondrial donation'. &lt;br /&gt;
&lt;br /&gt;
Under the 'Technical Progression' section it would be best to incorporate human embryo, mouse and human models under a sub-sub heading, as at the moment it feels a bit jumbled.&lt;br /&gt;
&lt;br /&gt;
I would also recommend moving the 'Benefits' heading towards the end of the page. It feels odd reading about the benefits of three person embryos before I gain a proper understanding of how they work. Also it might be worth talking about the disadvantages (if there are any) to three person embryos to balance out the 'benefits' section. As has been previously stated, make sure you sort out the copyright information for your video as it would be a shame to lose marks if it was missing. Also, don't forget to add the 'student template' to the 'Swapping mitochondrial DNA mammalian oocytes' image as it is currently absent.&lt;br /&gt;
&lt;br /&gt;
===3===&lt;br /&gt;
The entire project is presented simplistically and all the content is relevant and easy to understand. Majority of the flaws I found were based around poor grammar and syntax which could be fixed up with some editing. Below is a more detailed breakdown of some of the things you could fix.  &lt;br /&gt;
&lt;br /&gt;
Firstly, I liked that the introduction was brief and concise and gives the reader a basic understanding of the topic of three person embryo. The video was also informative and provided some background information around the topic. I was informed that mitochondrial DNA was the major factor concerning this topic however there was a lack of information about its importance to the body so a short summary could be included along with some examples of diseases it could cause. &lt;br /&gt;
&lt;br /&gt;
Also, the use of a timeline to present the history is a great idea and I think it could be improved and would look more aesthetically pleasing if it were to be placed into a table. I also think the 1990s, 2000s and 2010s label could be removed to make it look less clustered since they aren’t particularly necessary. &lt;br /&gt;
&lt;br /&gt;
Some information under the heading ‘Technical Progression’ has yet to be filled in but from what is there I’d like to suggest exchanging the bullet points for numbering instead for the information under ‘Pronuclear transfer’ and ‘Polar body transfer’ since they sounded like sequence steps as opposed to separate points. &lt;br /&gt;
&lt;br /&gt;
Finally, I found the layout of the table under the heading ‘Legal status’ to be very well put together. There are however some countries placed under the incorrect continents and I found that the order was easily changed and mixed up. I also noticed that several of the countries were linked to the same sources which made the information very unspecific. Instead of just links I think a few sentences explaining the legislation would be more informative.&lt;br /&gt;
&lt;br /&gt;
===4===&lt;br /&gt;
&lt;br /&gt;
I liked how you guys started the introduction and provides partially a brief overview of what your project is about. But I believe it is not enough to allow the audience an insight to your project page. This is something that needs to be worked on and maybe add some images also. However, the choice of short video used in the introduction is great. This is definitely a benefit for your page as it will reinforce the information you have been trying to get across. Like I mentioned, one thing you could work on is adding images and explaining the content in more depth. There is great amount of reference at the end of the page in the reference list which is fantastic!, however there is no in- text referencing in each section such as introduction or in some of the parts of the “Technical Progression” like “Cytoplasmic transfer” or “Spindle-chromosome transfer”.  Having in-text referencing will allow the audience to know exactly where the information was read from and for the interest of the audience can read that specific paper in detail.&lt;br /&gt;
&lt;br /&gt;
I also noticed that there are no information for “Benefits” and “Legal Status” or there is limited information for such headings like “Ethics”. I’m assuming you didn’t get the chance to upload information there or you haven’t had the time. This is something you need to work on so that the audience has some note of what this page is about. Also you need to change the format of the page for example it is to move the 'Benefits' heading towards the end of the page after the audience gained a good level of understanding of the project. You included some great images but be careful with copyright as I didn’t see it. But also consider some more images, tables, diagrams as well as hand drawn images in some sections, to make it more inviting and not overwhelming with just content. I do appreciate that the section of “Technical Progression” is subdivided into “Human Model”, timeline” and etc. But maybe consider adding in the current research, historic research, limitations and disadvantages to ensure that you can get all the marks possible by addressing all the key concepts. The timeline is a great idea that outlines the significant progresses and in turn helps put major events into perspective, making it more effective for students to study and understand.&lt;br /&gt;
&lt;br /&gt;
Well done on making the “Glossary” at the end. This is exactly what I would have expected to see and I used it while I was reading through your page. Also it is great to see the table in the “Prohibited” section but I would suggest you to write some sentences explaining the legislation rather than just pasting the links.&lt;br /&gt;
&lt;br /&gt;
Overall, this project page has room for improvement by giving certain sections of the page the attention they deserve. Images are imperative in allowing a balance between text and the image itself. Diagrams, tables and animations can sometimes be refreshing, and less overwhelming to see them among paragraphs of content. Try and work on time management, or set a group deadline that everyone has to meet so that all the information can be well up before the due date so your group can have time to edit and add images and play around with the page comfortably. Goodluck!&lt;br /&gt;
&lt;br /&gt;
===5===&lt;br /&gt;
&lt;br /&gt;
It would be nice if the history section could start earlier in time e.g. who came up with the idea of 3 person embryos. It kind of feels as though 3 person embryos popped out of nowhere. This is just a small nuance but the first sentence in “Hereditary mitochondrial Disease” doesn't really make sense.  It sounds incomplete. I think you have too many timelines going on in your page and it makes it a bit confusing. There is one under “History” and another timeline in “technical progression”. I understand they may be timelines for different things, but it’s all too much history. Maybe the “technical progression” timeline could be simplified into a paragraph?&lt;br /&gt;
&lt;br /&gt;
Some sections have too many subsections e.g. “technical progression”, and this makes the section messy and hard to read. It is however good for the table of contents though as it makes it easier to specify what you want to read on the page so my suggestion would be to keep some subheading but cut down a bit. You guys are listing papers to read too often. People want to have the information summarized for them on a wiki page, not have to outsource all the information themselves. It’s too time consuming and if they wanted to read a bunch of articles, they would go on PubMed themselves. However, I do like that some articles have been listed but maybe cut it down to one or two great ones instead of 4-5 etc.&lt;br /&gt;
 &lt;br /&gt;
I really like the table under the subheading “prohibited”, however, it would be nice to have a little summary next to the links about what each countries stance is, because again it’s too time consuming to have to read all those links. I also think some sections need a lot more work e.g. “ethics” and “benefits” and some more words could be added to the glossary. For example, a definition of what the word gamete mean would be good as, whilst we may know what it means, other people who view your page may not.&lt;br /&gt;
&lt;br /&gt;
I really likes the images you used in “technical” progression. They were easy to understand and simplified the text a lot. It would be good however to add a few more images, perhaps to “history”. Some hand-drawn ones would be good. You've got a good amount of references in there, just maybe add a few more. This indicates that you have done significant research and they appear to be correctly cited. The key points of your topic are clearly described and I feel as though your intro., whilst short, really opens up the topic well. Your page relates well to the learning aims of embryology. &lt;br /&gt;
&lt;br /&gt;
To conclude, I think you've got a great framework and some really good information in there. Just makes sure your page doesn't look too busy and is easy to read. A little bit more work needs to be done in some of the sections and a bit more technical touch ups and you should be good!&lt;br /&gt;
&lt;br /&gt;
===6===&lt;br /&gt;
&lt;br /&gt;
Your group’s topic looks very interesting! You have addressed the key points of your topic, and the placement of the video gives the reader a great overview of your project. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''COMMENDATIONS:'''&lt;br /&gt;
&lt;br /&gt;
•	Information has been organised well most of the time. Good use of bullet points and subheadings. &lt;br /&gt;
&lt;br /&gt;
•	The table under “Prohibitions” is a great way of summarising information, and it was easy to read.&lt;br /&gt;
&lt;br /&gt;
•	I like the addition of a glossary, however, more terms could be added here as a lot of jargon has been used in your text. &lt;br /&gt;
&lt;br /&gt;
•	Cytoplasmic transfer images were great as they aided the text well. These images could be re-sized as some of the text is blurry. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''RECOMMENDATIONS:'''&lt;br /&gt;
&lt;br /&gt;
•	Be mindful of spelling and capitalisation, e.g. “Hereditary Mitochondrial Disease” rather than “Hereditory mitochndrial Disease.”&lt;br /&gt;
&lt;br /&gt;
•	In terms of formatting, more spacing between major headings will make reading the page easier and will allow your information to flow.&lt;br /&gt;
&lt;br /&gt;
•	I recommend adopting a set formatting scheme for each section: i.e. make sure that the subheadings are all the same size, that they are in bold/italic (if that is what you intended).&lt;br /&gt;
&lt;br /&gt;
•	Some references and PMIDs are placed throughout the page. These should all be under your References heading at the end of the page.&lt;br /&gt;
&lt;br /&gt;
•	Information is missing under certain headings, e.g. “Mitochondria Linked Infertility.” I’m assuming that information from the two links provided will be summarised for the final submission.&lt;br /&gt;
&lt;br /&gt;
•	Hand drawn image is absent – maybe you could hand draw one of your timelines? (Seeing that both of them currently take the same format/structure). &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Great job so far!&lt;br /&gt;
&lt;br /&gt;
===7===&lt;br /&gt;
&lt;br /&gt;
Thus far, I think this page has a good layout to be a successful page on Three Person Embryos.  The headings and subheadings are relevant and show that you have conducted literature searches to deduce what information needs to be covered. I suggest moving “Benefits” below “Technical Progression” as it is important for the reader to understand the process of three person embryos, before learning its advantages. You could also add information about disadvantages and controversial issues. &lt;br /&gt;
&lt;br /&gt;
On a positive note, I am impressed with the way you have set up headings under “Technical Progression”. The consistency of discussing a model and current research provides a systematic approach to the viewing of your page, making it easy to understand. Delving further in each of these subheadings would provide a greater understanding of the current technologies available, such as including limitations and advantages, and statistics of their success rates. The timeline under “Cytoplasmic Transfer” could probably be incorporated with the timeline under “History” to equalize the amount of content under each heading.  &lt;br /&gt;
&lt;br /&gt;
The content under each heading still needs work in terms of editing and elaboration. There are quite a lot of grammatical and spelling errors such as “Timeline of Mitocondrial Donation” (missing an ‘h’ in mitochondrial), and some sentences aren’t finished. Proofreading would be key to making the information more understandable and effective to the reader. Information seems to be lacking under a few headings especially “Benefits”, “Hereditary Mitochondrial Disease”, “Mitochondria linked Infertility” and “Other approaches”. To make it a bit easier for yourselves, you may want to consider using a table, flow chart for pathogenesis of the disease, and a detailed diagram of the relevant heading. You have provided a table to explain the &amp;quot;Prohibited Section&amp;quot; however a very short description/summary of each source in the table would be very helpful. &lt;br /&gt;
&lt;br /&gt;
I also noticed you have not included many images, videos or tables. These visual aids really help the reader to understand the content in front of them, and also keep their interest in the topic so it imperative to focus on them as much as the content. &lt;br /&gt;
&lt;br /&gt;
The references have all been cited correctly and have shown you have performed adequate research to cover the important information for this topic. As you add more information, more references should be present within the body of your page. &lt;br /&gt;
&lt;br /&gt;
Overall, I think this page has a really good framework for further information to be added. With more editing, content and diagrams, you are sure to produce a wonderful Wiki page.&lt;br /&gt;
&lt;br /&gt;
===8===&lt;br /&gt;
Your project instills a great first impression on a visitor to the page! It is a well designed webpage that doesn’t come across as overwhelming and too wordy encouraging and drawing the reader to explore your page. Your choice of content is relevant and provides a good understanding of the topic so far. The introduction is nice and succinct, explaining easily and clearly what the topic is about with a great video that complements the introduction. Together they give the reader good background information on the topic, and are taught in a way that’s easy for someone with no prior knowledge on the topic or in embryology in general to understand. &lt;br /&gt;
&lt;br /&gt;
Furthermore, the timelines you provided, the ethics section and the table on the legal status of the technique is a good way of showing how far the concept has come and good at placing the technique in the context of how it has been translated into modern society. I really like that you have included animal models in explaining the various techniques, provided the current research available, and included further reading. This is very relevant and interesting for other embryology students and researchers who visit your page! The diagrams you have already chosen are very appropriate and explain the technique clearly to visual learners and are very engaging. &lt;br /&gt;
&lt;br /&gt;
In improving on your page I think the main focus is to elaborate on some key points further and add a few more diagrams and pictures so you can maintain a perfect balance of words and images and the engaging layout you already have begun. For example, maybe for the section “hereditary mitochondrial disease” you can talk about the type of hereditary diseases there are. Also, some of your wording and grammar need further editing so make sure you go through and reread your work. &lt;br /&gt;
&lt;br /&gt;
Other things you should edit include, adding a reference to your introductory paragraph and maybe clarifying that three person embryos are now legal in the UK since your video says “its on the threshold of acceptance”. Also check your copyright on some of the images such as the one that says “Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking”, I am not sure if this means you are allowed to use it so just clarify this.  &lt;br /&gt;
&lt;br /&gt;
Overall, you have great progress on your page so far, it has a great teaching element to it and shows extensive research and citing into the project!&lt;br /&gt;
&lt;br /&gt;
===9===&lt;br /&gt;
It’s great to begin with a introductory video which defines your topic.  I do suggest finding a reference for the first paragraph for the introduction.  Besides that, references have been cited correctly and shows that you have conducted extensive research, but remember to reference as you add information ( [##] ).  I think you guys did a great job with the heading and subheadings; it shows us that you have done extensive literature research, and have came to a conclusion as to what information was relevant.  Just a grammatical error made in “Timeline of Mitocondrial Donation” which is missing a H in mitochonidral. I suggest proof reading all the text before uploading!  This will make it easier for the audience to understand and also for yourself!  As to the “Benefit” heading, I think it will be a good idea to add information and case studies on disadvantages towards three person embryos.&lt;br /&gt;
&lt;br /&gt;
Nice to see that you guys have included a timeline, this shows the progress made throughout the years.  But I think there is still information that can be added into this area; for example: different possible approaches or more controversial issues that has emerged.  “Technical Progression” is an impressive choice of heading; I found it very interesting to read.  The cytoplasmic transfer images used were great! They were very easy to understand.  The “Timeline” under “Cytoplasmic transfer” could be merged with the history timeline heading above.&lt;br /&gt;
&lt;br /&gt;
Overall, I think more information and content needs to be added under all the headings and subheadings.  To make it easier for the audience to read, I suggest adding detailed images, tables and flowcharts.  It will be more eye-catching for readers and will keep them interested.  I see that you guys have a table under “Prohibited Section” however that just leads to another link, rather than having the link there; I think it would be a great improvement if there is a short summary of all the sources found.&lt;br /&gt;
&lt;br /&gt;
I think your page is organised and formatted very well! With more information/content, detailed diagrams and tables; it will further improve your Wiki Page! Good Luck.&lt;br /&gt;
&lt;br /&gt;
===10===&lt;br /&gt;
Firstly, this is a very impressive wiki and I think you guys are setting the bar very high. The resources you have used and referenced are of really high quality and demonstrate that you have carried out extensive research and identified the information that is most relevant and important. The introductory video and all the images you have included are awesome and really help to solidify the information that you are presenting; they also add more depth to the page and provide further explanation and clarification of the information. The &amp;quot;Technical Progression&amp;quot; section is really great, well structured and provides a lot of explanation about the procedure that I found aided my understanding about major the concepts of the page. &lt;br /&gt;
&lt;br /&gt;
My suggestions to improve your wiki page would be to have a second look at the layout and headings; I found they were difficult to follow and disrupted the flow of the page, for example the heading &amp;quot;Benefits&amp;quot; followed immediately by &amp;quot;Mitochondrial linked information&amp;quot; which was followed again almost immediately by &amp;quot;Hereditary Mitochondrial Disease&amp;quot;. These headings made me stop and think about whether there was some information missing and I was just a little confused about whether the two latter headings came under the first. I really liked the inclusion of the legislation and ethics surrounding the topic (very interesting reading), however I am a bit concerned that they are the biggest portions of the page; I think this would be easily rectified by simple adding further explanations of the current research and journal articles that you have referred to instead of providing only one or two sentences about each. Lastly, it would be really interesting to present information about the controversial opinions/incidents surrounding the topics and also about the disadvantages of the procedures. &lt;br /&gt;
&lt;br /&gt;
Over all, I think you guys have done an awesome job thus far and with a few minor changes the page will be amazing! Good Luck!&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204893</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204893"/>
		<updated>2015-10-09T12:06:07Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Risk Factors and Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatozoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatozoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatozoa morphology, spermatozoa concentration and motility, total spermatozoa count and percentage of vital spermatozoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204891</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204891"/>
		<updated>2015-10-09T12:04:34Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Causes of Infertility */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatozoa to result in pregnancy, or inefficient transport of spermatozoa. The three key parameters for assessing male infertility are spermatozoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatozoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatozoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatozoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatozoa concentration and evem azoospermia, the absence of motile spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatozoa) and oligozoospermia (low spermatozoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatozoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatozoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatzoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatozoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatozoa DNA damage resulting in a decline in semen volume, spermatozoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatozoa: Spermatozoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatozoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatozoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatozoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatozoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatozoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatozoa and even the reduced ability of spermatozoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatazoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatazoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatazoa morphology, spermatazoa concentration and motility, total spermatazoa count and percentage of vital spermatazoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
Varicocele repair can be performed by either percutaneous radiographic embolization or surgery to correct male infertility &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;. The desired outcome of these procedures is to lower the temperature of the scrotum for normal spermatogenesis to occur. &lt;br /&gt;
&lt;br /&gt;
Percutaneous radiographic embolization involves the catheterization of the internal spermatic vein and its occlusion using a sclerosant (injectable irritant) or solid embolic devices such as stainless steel coils &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The administration of the sclerosant and solid embolic devices are given at the level of the inguinal crease and ligament respectively to prevent the backflow of blood into the pampiniform plexus. This method is much less invasive than surgical procedures and has very high success rates, and low recurrence rates &amp;lt;ref name=PMIDPMC2422968 &amp;gt;&amp;lt;pubmed&amp;gt;PMC2422968&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
As for the surgical approach, these methods are far more invasive but variable in terms of success rates and recurrence. It is important to note that all of these varicocele repair methods, surgery and embolisation, aim to impede increasing temperature of the scrotum caused by the pampiniform plexus. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Surgical Approach to Varicocele Repair'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Surgical Method of Varicocele Repair'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Inguinal Surgery ''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Involves opening the inguinal canal and the incision of the varicocele vein &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows preservation of lymphatic vessels&lt;br /&gt;
*Takes longer to heal &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Subinguinal Surgery'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*Incision below external inguinal ring&lt;br /&gt;
*Less pain due to the area of incision as it avoids the aponeurosis (flat tendon) of the abdominal external oblique muscle &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Retroperitoneal Surgery''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| &lt;br /&gt;
*Ligation of the internal spermatic vein &lt;br /&gt;
*Can be performed as a mass ligation involving the artery, vein and lymphatic vessels, or artery sparing ligation preserving lymphatic vessels &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Laparoscopic Varicocelectomy'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| &lt;br /&gt;
*At the level of the internal inguinal ring, the internal spermatic vein is ligated while sparing the corresponding artery &amp;lt;ref name=Tu&amp;gt;Tu, D., &amp;amp; Glassberg, K. (2010). Laparoscopic varicocelectomy. BJU International, 106(7), 1094-1104. http://dx.doi.org/10.1111/j.1464-410x.2010.09709.x&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Allows for a more accurate identification of vessels within the area &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204871</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204871"/>
		<updated>2015-10-09T11:27:24Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Lifestyle Factors */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatazoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatazoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatazoa morphology, spermatazoa concentration and motility, total spermatazoa count and percentage of vital spermatazoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204869</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204869"/>
		<updated>2015-10-09T11:26:22Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Risk Factors and Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatazoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatazoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatazoa morphology, spermatazoa concentration and motility, total spermatazoa count and percentage of vital spermatazoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Physical trauma''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| It has been demonstrated that physical traumas and vigorous exercise (often a combination of the two) can result in adverse urogenital disorders such as torsion of the spermatic cord, penile thrombosis, hematuria and infertility. &amp;lt;ref name=PMID15716187&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204859</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204859"/>
		<updated>2015-10-09T11:09:24Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Risk Factors and Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatazoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatazoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatazoa morphology, spermatazoa concentration and motility, total spermatazoa count and percentage of vital spermatazoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204857</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204857"/>
		<updated>2015-10-09T11:07:54Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Risk Factors and Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatazoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatazoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatazoa morphology, spermatazoa concentration and motility, total spermatazoa count and percentage of vital spermatazoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
1. &amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt; &lt;br /&gt;
Smoking&lt;br /&gt;
&lt;br /&gt;
2. &amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol and cigarette smoking&lt;br /&gt;
&lt;br /&gt;
3. &amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol&lt;br /&gt;
&lt;br /&gt;
4. &amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Prevalence of low ejaculate volume in overweight and obese men, but still needs further investigation to understand role of weight loss in fertility.&lt;br /&gt;
&lt;br /&gt;
5. &amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;quot;High BMI is negatively associated with semen characteristics and serum levels of AMH (Anti-Mullerian Hormone)&amp;quot;&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204855</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204855"/>
		<updated>2015-10-09T11:06:34Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=Cocuzzo&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele (vein dilatation) only palpable during Valsalva manoeuvre on physical exam&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Varicocele palpable on physical exam without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Varicocele visible through the scrotal skin without performing Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Risk Factors and Prevention==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Risk Factors of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Risk Factors'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Smoking''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Semen quality is significantly affected by cigarette smoke. Light smoking has been associated with asthenozoospermia and heavy smoking has been associated with asthenozoospermia, teratozoospermia and oligozoospermia. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Alcohol Consumption'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Alcohol abuse in men has been associated with impaired production of testosterone and therefore infertility. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt; 20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; One study demonstrated that a typical weekly alcohol consumption of ~40 units resulted in a 33% decrease is spermatazoa concentration. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Alcohol abuse adversely affects spermatazoa morphology and production ultimately causing asthenozoospermia and therefore reducing the quality of semen. &amp;lt;ref name= PMID20090219&amp;gt;&amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Overweight/Obesity''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| An increase in waist circumference is associated with impaired semen parameters in infertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A high body mass index (BMI) is negatively associated with normal spermatazoa morphology, spermatazoa concentration and motility, total spermatazoa count and percentage of vital spermatazoa, therefore negatively affecting male fertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Psychiatric Considerations'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Stress has been demonstrated to have a negative affect on fertility, reducing testosterone levels and spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22177463&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
1. &amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt; &lt;br /&gt;
Smoking&lt;br /&gt;
&lt;br /&gt;
2. &amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol and cigarette smoking&lt;br /&gt;
&lt;br /&gt;
3. &amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol&lt;br /&gt;
&lt;br /&gt;
4. &amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Prevalence of low ejaculate volume in overweight and obese men, but still needs further investigation to understand role of weight loss in fertility.&lt;br /&gt;
&lt;br /&gt;
5. &amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;quot;High BMI is negatively associated with semen characteristics and serum levels of AMH (Anti-Mullerian Hormone)&amp;quot;&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204843</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204843"/>
		<updated>2015-10-09T10:19:21Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Damage to DNA */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
[[File:Causes of Increased DNA Damage.jpg|thumb|right| Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility.]]&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| only palpable during Valsalva manoeuvre&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| palpable without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| visible without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Prevention==&lt;br /&gt;
&lt;br /&gt;
1. &amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt; &lt;br /&gt;
Smoking&lt;br /&gt;
&lt;br /&gt;
2. &amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol and cigarette smoking&lt;br /&gt;
&lt;br /&gt;
3. &amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol&lt;br /&gt;
&lt;br /&gt;
4. &amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Prevalence of low ejaculate volume in overweight and obese men, but still needs further investigation to understand role of weight loss in fertility.&lt;br /&gt;
&lt;br /&gt;
5. &amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;quot;High BMI is negatively associated with semen characteristics and serum levels of AMH (Anti-Mullerian Hormone)&amp;quot;&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204839</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204839"/>
		<updated>2015-10-09T10:17:11Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Lifestyle Factors */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
[[File:Non-viable spermatazoa.jpg|thumb|right|Non-viable spermatazoa: Spermatazoa stained pink by eosin due to a damaged membrane resulting in poor semen quality.]]&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis resulting in poor semen quality. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| only palpable during Valsalva manoeuvre&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| palpable without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| visible without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Prevention==&lt;br /&gt;
&lt;br /&gt;
1. &amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt; &lt;br /&gt;
Smoking&lt;br /&gt;
&lt;br /&gt;
2. &amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol and cigarette smoking&lt;br /&gt;
&lt;br /&gt;
3. &amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol&lt;br /&gt;
&lt;br /&gt;
4. &amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Prevalence of low ejaculate volume in overweight and obese men, but still needs further investigation to understand role of weight loss in fertility.&lt;br /&gt;
&lt;br /&gt;
5. &amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;quot;High BMI is negatively associated with semen characteristics and serum levels of AMH (Anti-Mullerian Hormone)&amp;quot;&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204835</id>
		<title>2015 Group Project 4</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2015_Group_Project_4&amp;diff=204835"/>
		<updated>2015-10-09T10:13:19Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Damage to DNA */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{ANAT2341Project2015header}}&lt;br /&gt;
&lt;br /&gt;
=Male Infertility=&lt;br /&gt;
&lt;br /&gt;
Infertility is defined as the inability to achieve a clinical pregnancy after 12 months of unprotected sexual intercourse &amp;lt;ref&amp;gt;The World Health Organisation,. (2015). Human Reproductive Programme | Sexual and Reproductive Health. Retrieved 4 September 2015, from http://www.who.int/reproductivehealth/topics/infertility/definitions/en/ &amp;lt;/ref&amp;gt;. Male infertility is the inability for a male to successfully impregnate a fertile female. Infertility is an ever increasing issue that affects one in six Australian couples as reported in the Australian Government Department of Health, ''National Women's Health Policy''. &amp;lt;ref&amp;gt;The Department of Health,. (2011). Department of Health | Fertility and infertility. Health.gov.au. Retrieved 2 September 2015, from http://www.health.gov.au/internet/publications/publishing.nsf/Content/womens-health-policy-toc~womens-health-policy-experiences~womens-health-policy-experiences-reproductive~womens-health-policy-experiences-reproductive-maternal~womens-health-policy-experiences-reproductive-maternal-fert&amp;lt;/ref&amp;gt; Of these couples who are considered infertile, one in five experience problems that lie solely with the male.&lt;br /&gt;
&lt;br /&gt;
==Background Information==&lt;br /&gt;
[[File:Components and structure of Spermatozoa.jpeg|300px|thumb|right|Virtual preparation of the spermatozoon showing the acrosome, the nucleus and nuclear envelopes, the mitochondrial sheath of the main piece of the flagellum]]&lt;br /&gt;
[[File:Structure of the seminiferous tubule.jpeg|300px|thumb|right|Structure of the seminiferous tubule: site of the germination, maturation, and transportation of the sperm cells within the male testes]]&lt;br /&gt;
===Structure of spermatozoa===&lt;br /&gt;
The shape of spermatozoa are suitable for the transport to female gametes via the uterine tube.  For this reason the nucleus of the spermatozoa is highly condensed, covered by an acrosome filled with enzymes for establishing contact to the female gamete.  The enzyme within the acrosome degrades the zona pellucida of the oocyte (female gamete), allowing membrane fusion.  Spermatozoa also consist of a flagellum for progressive motility during the transport throughout the epididymal ducts.  The motility is supported by the mitochondrial sheath found in the mid piece of the spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Holstein AF, Roosen-Runge EC. Atlas of Human Spermatogenesis. Berlin: Grosse; 1981&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Spermatogenesis===&lt;br /&gt;
The complete process of male germ cell development is called spermatogenesis, male germ cells develop in the seminiferous tubules of the testes throughout life from puberty to old age. The product of spermatogenesis are mature male gametes called spermatozoa. There are three major stages in spermatogenesis: &lt;br /&gt;
&lt;br /&gt;
1. Spermatogoniogenesis &lt;br /&gt;
&lt;br /&gt;
2. Maturation of spermatocytes &lt;br /&gt;
&lt;br /&gt;
3. Spermiogenesis (which is the cytodifferentiation of spermatids)&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;Spermatogoniogenesis&amp;lt;/b&amp;gt; is the process where spermatogonia multiplicate continuously in successive mitosis. However, the daughter cells will still be interconnected by cytoplasmic bridges and is only dissolved in advanced stages of spermatid development. The stage of &amp;lt;b&amp;gt;meiosis&amp;lt;/b&amp;gt; is manifested through changes in the structure of the nucleus after the last spermatogonial division. Cells undergoing meiosis are called spermatocytes. As the process of meiosis comprises two divisions, cells before the first division are called primary spermatocytes and before the second division secondary spermatocytes. During the prophase the duplication of DNA, the condensation of chromosomes, the pairing of homologuous chromosomes and crossing over take place. After division the germ cells become secondary spermatocytes. They do not undergo DNA-replication and divide quickly to the spermatids. This results in four haploid cells, namely the spermatids. These differentiate into mature spermatids, a process called spermiogenesis which ends when the cells are released from the germinal epithelium. At this point, the free cells are called spermatozoa. During &amp;lt;b&amp;gt;spermiogenesis&amp;lt;/b&amp;gt; three processes takes place; condensation of the nucleus, formation of acrosome cap filled with enzymes and the development of flagellum structures and their attachment to the head/mid piece of the developing spermatozoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;14617369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Physiology of fertility in Males===&lt;br /&gt;
Normal reproductive functioning in males is controlled by gonadotropin releasing hormone (GnRH), androgens and gonadatropins. The correct metabolism and functioning of all three types of hormones is essential to the normal and efficient production of spermatazoa, as well as over all reproductive health. GnRH is synthesised and released by the hypothalamus, which stimulates the anterior pituitary to release two gonadatropins: follicle stimulating hormone (FSH) responsible for spermatogenesis in the Sertoli cells and luteinizing hormone (LH) responsible for stimulating the release of androgens by the Leydig cells. Testosterone, the primary androgen, is released into the testes and aids FSH by further promoting spermatogenesis. Furthermore, testosterone is vital to the normal development of many accessory reproductive organs, including the accessory glands. A negative feedback loop of testosterone and inhibin (secreted by Sertoli cells) acts on the anterior pituitary, either decreasing or stimulating the release of FSH and LH. &amp;lt;ref&amp;gt;Stanfield, L. C. Pearson New International Edition ''Principles of Human Physiology Fifth Edition''&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Male infertility disorders==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Types of Male Infertility'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Type'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Oligospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Low spermatozoon count &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Asthenospermia (asthenozoospermia)'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Reduced motility of spermatozoa within the semen&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Teratozoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Abnormal spermatozoa morphology within the semen &lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Oligoasthenozoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Combination of reduced motility of spermatozoa (asthenospermia) and low spermatozoa count (oligospermia)&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Obstructive Azoospermia''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| Absence of spermatozoa within the semen due to a blockage in the genital tract obstructing the pathway for sperm to enter the penis from the testes&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Non-obstructive Azoospermia'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| Absence of spermatozoa within the semen due to sperm producing cells being damaged or destroyed &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Causes of Infertility== &lt;br /&gt;
Due to the increasing rates of male infertility worldwide, researchers have been focusing on aetiological factors for its treatment and prevention. There are numerous causes of male infertility, however, the most common causes are those that relate to the correct development and adequate supply of spermatazoa to result in pregnancy, or inefficient transport of spermatazoa. The three key parameters for assessing male infertility are spermatazoa count, viability and motility&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;html5media height=&amp;quot;300&amp;quot; width=&amp;quot;400&amp;quot;&amp;gt;https://www.youtube.com/watch?v=joTrmeDf1dY&amp;lt;/html5media&amp;gt;&lt;br /&gt;
Infertility: Causes Behind Infertility &amp;lt;ref&amp;gt;St Pete Urology. (2011, September 14) Infertility: Causes Behind Infertility. Retrieved from https://www.youtube.com/watch?v=joTrmeDf1dY &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Major Causes of Male Infertility===&lt;br /&gt;
&lt;br /&gt;
====Varicocele====&lt;br /&gt;
&lt;br /&gt;
[[File:Varicocele induced cytoplasmic apoptosis.jpg|thumb|right| Varicocele induced cytoplasmic level apoptosis in animals: inadequate energy supply results in the cells ability to utilise lipids as a secondary energy source to be reduced, therefore reducing normal cellular functioning and division and ultimately leading to cytoplasmic level apoptosis.]]&lt;br /&gt;
&lt;br /&gt;
Varicocele is one of the leading causes of infertility in males and affects one third of individuals classified as infertile. Varicocele is the abnormal dilation of the internal spermatic veins and creamasteric veins from the panpiniform plexus as a result of back flow of blood. This downward flow of blood into the panpiniform plexus is due to the absence or presence of incomplete valves within the veins. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt; As previously mentioned, the three key markers of spermatozoa quality and of male infertility, spermatazoa viability, count and motility, are also heavily associated with varicocele. &amp;lt;ref&amp;gt;Cocuzzo, M. Cocuzzo, M. A. Bragais, F. M/ P. Agarwal, A. (2008) The role of varicocele repair in the new era of assisted reproductive technologies. ''Clinics Vol. 63, No. 6'' retrieved 2nd September 2015, from http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S1807-59322008000300018&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en&amp;lt;/ref&amp;gt; Other causes of varicocele include an increase in programmed cell death (apoptosis), increased scrotal temperature of approximately 2.5 degrees Celcius and reduced androgen secretion leading to testosterone deprivation. &amp;lt;ref&amp;gt;Marmar, L.J. (2001) Varicocele and Male Infertility Part II: The pathophysiology of varicoceles in the light of current molecular and genetic information. ''Human Reproduction Update, Vol. 7, No. 5 pp. 461-472'' retrieved 2nd September 2015, from http://humupd.oxfordjournals.org/content/7/5/461.long&amp;lt;/ref&amp;gt;  Testosterone is one of the hormones that play a major role in the correct physiological functioning of the male reproductive system. It is therefore evident that a deprivation of testosterone severely affects the rate of production of spermatazoa, their maturation as well as the male reproductive systems ability to effectively ejaculate semen (related to the development of accessory glands).&lt;br /&gt;
&lt;br /&gt;
====Male Reproductive Cancers====&lt;br /&gt;
&lt;br /&gt;
Male reproductive cancers, including prostate cancer and testicular cancer, have been shown to dramatically decrease the quality of semen prior to treatment, being comparable with that of infertile and subfertile men. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25837470&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; A link between testicular cancer and male infertility has been established by the identification of Testicular Dysgenesis Syndrome (TDS). The improper or abnormal development of the testicles associated with TDS has direct links to Sertoli and Leydig cell disfunction leading to failure of gonocyte maturation and therefore insufficient or low production of mature spermatazoa; one of the key indicators of male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21044369&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Furthermore, the presence of tumors in the male reproductive system have systemic effects including immunological and cytotoxic effects on the germinal epithelial leading to reduction in the quality of sperm produced and changes in the processes of spermatogenesis. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15192446&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has also been suggested that the fever and malnutrition associated with cancer may lead to alterations in spermatogenesis, a large decrease in spermatazoa concentration and evem azoospermia, the absence of motile spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11929007&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Chromosomal Abnormalities====&lt;br /&gt;
&lt;br /&gt;
Chromosomal Abnormalities are responsible for approximately 5% of all cases of male factor infertility and result in azoospermia (absence of spermatazoa) and oligozoospermia (low spermatazoa concentration). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;20103481&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Aneuploidy is the presence of an incorrect number of chromosomes and is the most common error of chromosomal abnormality resulting in infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16491264&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Klinefelter syndrome occurs in approximately 5% of severe oligozoospermic and 10% of azoospermic men and causes the cessation of spermatogenesis at the primary spermatocyte stage. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15509635&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another aneuploidy associated with male infertility is Y-chromosome microdeletions, present in 10-15% of azoospermic and 5-10% of severe oligozoospermic men, that can result in lack of spermatazoa in ejaculate (AZFa deletion), arrest of spermatogenesis at primary spermatocyte stage (AZFb deletion) and low concentration of spermatazoa (AZFc deletion). &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11294825&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26385215&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Damage to DNA====&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
DNA damage in the germ cell population of males has been shown to be a contributing factor to many adverse clinical outcomes including poor semen quality, low fertilisation rates and impaired pre-implantation development; an outcome significant in the use of Assisted Reproductive Technologies when treating infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16793992&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The integrity of spermatazoa can be negatively impacted by deficits in the DNA repair pathways resulting in decrease in germ cell survival and the production of spermatazoa. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;18175790&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It has been demonstrated that common inherited variants within genes that encode enzymes utilised in the mismatch repair pathway have a negative relationship with the maintenance of genome integrity, meiotic recombination and even gametogenesis, therefore increasing the risk of DNA damage in spermatazoa and male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22594646&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Finally, it has been demonstrated that an increase in age is associated with increased spermatazoa DNA damage resulting in a decline in semen volume, spermatazoa motility and morphology and over all semen quality. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;22429861&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Lifestyle Factors====&lt;br /&gt;
&lt;br /&gt;
There are numerous lifestyle factors that are associated with a decrease in male fertility that often cause irreversible damage to processes in gametogenesis. Tobacco smoking has been seen to increase risk of male infertility by up to 30% due to the competitive binding of cadmium to DNA polymerase, replacing zinc and causing damage to the testes. &amp;lt;ref name= PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; It was also suggested by the same study that excessive alcohol intake has an adverse affect on spermatazoa quality and chromosome number. &amp;lt;ref name=PMID16192719&amp;gt;&amp;lt;pubmed&amp;gt;16192719&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another lifestyle factor that produces adverse clinical outcomes to male infertility is obesity and its association with hypogonadatropic hypogonadism; a condition characterised by a decrease in functional activity of the gonads (hormone production and therefore gametogenesis). &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies conducted on animals demonstrates that a sensitivity to leptin in the hypothalamus as a result of obesity, decreases Kiss1 expression, therefore decreasing the release of gonadatropin releasing hormone (GnRH) and ultimately resulting in hypogonadatropic hypogonadism. &amp;lt;ref name=PMID21546379&amp;gt;&amp;lt;pubmed&amp;gt;21546379&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Studies have demonstrated vigorous physical exercise such as bicycle riding and horse riding, has been associated with urogenital disorders including erectile dysfunction, torsion of the spermatic cord and infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;15716187&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Immunological Infertility====&lt;br /&gt;
&lt;br /&gt;
Spermatogenesis commences at puberty after the body has developed a neonatal immune tolerance, therefore, without the necessary and correctly functioning physiological mechanisms such as the blood-testis barrier to separate the spermatazoa from the body's immune response, Sperm-reactive antibodies (SpAb) form and can be found attached to spermatazoa or within the semen. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SpAb's have been found present in approximately 5-6% of infertile males.&amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=PIMD2069684&amp;gt;&amp;lt;pubmed&amp;gt;2069684&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Various microbial pathogens can infect the testes via the circulating blood or the urogenital tract, which can result in orchitis (the inflammation of one or both testicles); characterised by the infiltration of leukocytes into the testes and damage of the seminiferous epithelium, ultimately contributing to male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;24954222&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The disruption of tight junctions within the epididymis, rete testes and even efferent ducts due to inflammation or trauma can result in the exposure of spermatazoa proteins to the immune system and therefore the formation of SpAb's. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The presence of SpAb's on the surface of spermatazoa contribute to infertility by causing agglutination in seminal plasma, reduced motility characterised by &amp;quot;shaking&amp;quot; of spermatazoa and even the reduced ability of spermatazoa to penetrate the cervical mucous of the female. &amp;lt;ref name=PMID12385832&amp;gt;&amp;lt;pubmed&amp;gt;12385832&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diagnosis== &lt;br /&gt;
Male infertility is a widespread condition.  There are different diagnostic techniques to detect male infertility, from medical histories, physical examinations to sophisticated tests such as blood tests, ultrasounds and semen analysis.  Most cases, there are no obvious signs showing infertility.  Sexual intercourse, erections and ejaculations occur usually without any difficulty; the quantity and sperm count of the ejaculated semen are not noticeable with the naked eye.&lt;br /&gt;
&lt;br /&gt;
[[File:Stages of spermatogonia.jpeg|300px|thumb|right|Infertile patient with arrest of spermatogenesis at the stage of spermatogonia]]&lt;br /&gt;
&lt;br /&gt;
===Physical examination===&lt;br /&gt;
The physical examination focuses on the size and consistency of the genitals (testicles, epididymus and vas deferens) but also the overall body build.  Noting the distribution of body hair and presence or absence of gynecomastia, which is the enlargement of male breasts due to the imbalance of hormones or hormone therapy. In some cases, by examining the size and consistency of the scrotum it is possible to palpate whether or not the epididymis may have hardened from a possible inflammation.  Other cases may suggest obstruction within the ducts,this is determined by observing and examining the prostate size and consistency, checking for the presence of cysts or enlarged seminal vesicles.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Varicoceles are the most common abnormal finding in infertile men, typically diagnosed by physical examination of Valsalca manoeuvre.  It is performed by forceful attempts of exhalation against closed airways by closing one's mouth and pinching their nose while pressing out.  This strain increases their intrathoracic pressure and causes the venous return to the heart to decrease and increases the peripheral venous pressure.&amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Varicoceles can be diagnosed by conducting Valsalva manoeuvre. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Classifications of Valsalva manoeuvre'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Grade'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Description'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 1''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| only palpable during Valsalva manoeuvre&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Grade 2'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| palpable without Valsalva manoeuvre&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Grade 3''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| visible without Valsalva manoeuvre&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Semen Analysis===&lt;br /&gt;
Although the semen parameters of fertile men can vary, semen analysis is an initial and crucial laboratory test when determining male infertility. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  Every 2 to 4 weeks, at least two semen samples should be collected.  2 to 4 days prior to the collection is the abstinence period; this is important as it will increase the sperm destiny by 25%.  Semen samples are obtained by masturbation or by using a latex free, spermicide free condom during intercourse.&lt;br /&gt;
&lt;br /&gt;
Semen samples are required to liquefy before being studied under the microscope.  &lt;br /&gt;
&lt;br /&gt;
===Testicular Colour Dopple Ultrasound===&lt;br /&gt;
High resolution color Doppler ultrasound is a noninvasive means of simultaneously imaging and evaluating the blood flow to the testes in infertile men.  It is not generally performed as a routine examination, however physical examination may miss intrascrotal abnormalities readily detected by dopple ultrasound.  Non-palpable intrascrotal abnormalities includes testicular and epididymal lesions and tumour. &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;25038770&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21243017&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;16903932&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Prevention==&lt;br /&gt;
&lt;br /&gt;
1. &amp;lt;pubmed&amp;gt;17304390&amp;lt;/pubmed&amp;gt; &lt;br /&gt;
Smoking&lt;br /&gt;
&lt;br /&gt;
2. &amp;lt;pubmed&amp;gt;20090219&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol and cigarette smoking&lt;br /&gt;
&lt;br /&gt;
3. &amp;lt;pubmed&amp;gt;25277121&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Alcohol&lt;br /&gt;
&lt;br /&gt;
4. &amp;lt;pubmed&amp;gt;24306102&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Prevalence of low ejaculate volume in overweight and obese men, but still needs further investigation to understand role of weight loss in fertility.&lt;br /&gt;
&lt;br /&gt;
5. &amp;lt;pubmed&amp;gt;26067627&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&amp;quot;High BMI is negatively associated with semen characteristics and serum levels of AMH (Anti-Mullerian Hormone)&amp;quot;&lt;br /&gt;
&lt;br /&gt;
==Treatments==&lt;br /&gt;
&lt;br /&gt;
Current treatments for male infertility aim to eliminate the causative factors mentioned above. These may involve improving the male's fertility using drug therapies or surgical procedures, however many assisted reproductive technologies have been introduced and have proven successful. Both methods of treatment have shown evidence of efficacy, thus having great implications on infertile couples worldwide.&lt;br /&gt;
&lt;br /&gt;
===Non-surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
In order to effectively treat male infertility, it is imperative to correctly identify the specific cause and contributing factors. Currently, the different treatment strategies used or investigated tend to the specific aetiological factors for male infertility. Apart from theoretically allowing natural conception, these treatments also have an implication on the assisted reproductive technologies (ARTs) that are currently available. &lt;br /&gt;
&lt;br /&gt;
====Injectable Hormones &amp;amp; Fertility Drugs====&lt;br /&gt;
&lt;br /&gt;
Hormonal imbalance is a non-obstructive cause for male infertility. The efficiency of spermatogenesis depends on stimulation and regulation mainly by gonadotropins, GnRH and testosterone, without which may cause infertility. Males that have a deficiency in these hormones are being targeted by research involving injectable hormones such as human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG), and Clomiphene citrate, a fertility drug. hCG and hMG are gonadotropins that are used to treat male hypogonadotropic hypogonadism (MHH), a condition associated with infertility causing an underproduction of sperm or testosterone, or both &amp;lt;ref name=PMID26019400&amp;gt;&amp;lt;pubmed&amp;gt;26019400&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. These gonadotropins have been utilised in infertile males to stimulate the synthesis of testosterone and sperm directly, bypassing the pituitary gland that normally releases gonadoptropins LH and FSH. LH triggers Leydig cells to release testosterone, and FSH plays a vital role in spermatogenesis maintenance as it promotes Sertoli cell maturation &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, clomiphene citrate also increases secretion of GnRH from the hypothalamus, and FSH and LH from the pituitary gland by blocking feedback inhibition of serum estradiol &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Normally, males have more testosterone levels than estrogen however those with MHH and consequent infertility, may have the opposite &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16422830&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This was investigated in a study conducted in 2013 by Hussein et al. showing that hCG, hMG and clomiphene citrate are suitable treatments particularly for azoospermia, increasing levels of FSH, LH and total testosterone &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore the administration of these substances may correct abnormal hormone levels that contribute to male infertility, thus stimulates spermatogenesis to increase spermatozoa count, motility and viability.&lt;br /&gt;
&lt;br /&gt;
====Antioxidants====&lt;br /&gt;
&lt;br /&gt;
There has been increasing evidence that infertility may be directly linked to oxidative stress, thus various antioxidants have been experimented with to determine their efficacy as a treatment. Reactive oxygen species (ROS) formed during oxidation plays a vital role in sperm function, particularly in capacitation, acrosome reaction, hyperactivation and sperm-oocyte fusion &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. In low concentrations, ROS are essential for the synthesis of energy, and contribute to signal transduction pathways within the cell. Usually ROS levels are regulated by natural antioxidants within the seminal plasma &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. However an influx of ROS and/or a deficiency in antioxidants due to abnormal sperm or environmental stress, can lead to oxidative stress. Spermatozoal cell membranes contain high amounts of polyunsaturated fatty acids that consist of several electron-containing double bonds. The electrons of these fatty acids contribute to the formation of ROS and oxidative stress, thus causing a disruption in the flexibility of the spermatozoal membrane and diminishing the motility and sustainability of sperm &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. This may result in sperm membrane lipid peroxidation, DNA fragmentation, and apoptosis &amp;lt;ref name=PMID24675655&amp;gt;&amp;lt;pubmed&amp;gt;24675655&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The following are a few antioxidants that have been proven to treat oxidative stress, hence improves male fertility. &lt;br /&gt;
&lt;br /&gt;
'''1. Carotenoids''' &lt;br /&gt;
: Carotenoids are naturally occurring pigments produced by plants, algae, and photosynthetic bacteria &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. They can be divided into 2 different categories based on their chemical composition including carotenes that contain oxygen, and xanthophylls that only contain hydrocarbons &amp;lt;ref name=Higdon&amp;gt;Higdon, J., &amp;amp; Drake, V. (2009). Carotenoids | Linus Pauling Institute | Oregon State University. Lpi.oregonstate.edu. Retrieved 5 October 2015, from http://lpi.oregonstate.edu/mic/articles/dietary-factors/phytochemicals/carotenoids&amp;lt;/ref&amp;gt;. The main source of these chemical compounds in the human diet are from fruits and vegetables as they give them their yellow, red and orange pigments. The role of carotenoids within the healthcare industry are forever growing as they have been suggested supplements for the human body, and as treatments for various cancers and possibly infertility disorders &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;12134711&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. The antioxidant activity of carotenoids is performed by quenching (deactivating) singlet oxygen that is formed during photosnythesis by plants.&lt;br /&gt;
[[File:Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility.jpeg|300px|thumb|right|Proposed Mechanisms of Lycopene Treatment for Idiopathic Male Infertility]]&lt;br /&gt;
&lt;br /&gt;
: '''Lycopenes''' are a type of carotene carotenoid that is found in various fruits and vegetables such as tomatoes and watermelon. Despite it being a source of vitamin A, it also possesses strong antioxidant properties as it is one of the most effective quenchers of singlet oxygen &amp;lt;ref name=PMID12899230&amp;gt;&amp;lt;pubmed&amp;gt;12899230&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Although the exact mechanism of lycopenes is yet to be known, they have a role inneutralizing ROS and hindering their activity, achieved by their ability to donate an electron to free radicals &amp;lt;ref name=PMID19439288&amp;gt;&amp;lt;pubmed&amp;gt;19439288&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. As a result of this antioxidation pathway, lipid peroxidation is inhibited allowing for spermatozoal membranes to be retained and protected from further damage.  Lycopenes have also been suggested to increase natural antioxidant enzymes indirectly, and also decrease the production of pro-inflammatory agents. &lt;br /&gt;
&lt;br /&gt;
: '''Astaxanthin''' is a keto-carotenoid produced naturally from the microalgae ''Hematococcus pluvialis'' &amp;lt;ref&amp;gt;Willett, E. (2015). Studies Show Astaxanthin May Improve Sperm Health &amp;amp; Fertilization Rates. Natural-fertility-info.com. Retrieved 7 October 2015, from http://natural-fertility-info.com/astaxanthin-for-sperm-health.html&amp;lt;/ref&amp;gt;. Due to its higher antioxidant activity in comparison to vitamin E, a fat solube antioxidant found in soybean and margarine, it has been suggested as an effective treatment and supplement for male factor infertility. An experimental trial to test Astaxanthin’s influence on sperm function was carried out in 2005 in 27 infertile men &amp;lt;ref name=PMID16110353&amp;gt;&amp;lt;pubmed&amp;gt;16110353&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. It was found that Astaxanthin allowed for the following:&lt;br /&gt;
*Increased motility concentration&lt;br /&gt;
*Improved sperm morphology and motility&lt;br /&gt;
*Decrease in ROS and Inhibin B (a regulator of spermatogenesis) levels &lt;br /&gt;
&lt;br /&gt;
[[File:Model of the Activities of Cerium Dioxide Nanoparticles.jpeg|300px|thumb|right|Model of the Activities of Cerium Dioxide Nanoparticles]] &lt;br /&gt;
'''2. Cerium dioxide nanoparticles (CNPs)'''&lt;br /&gt;
: Cerium dioxide nanoparticles have been used extensively in the health care industry as potential pharmacological agents to treat various conditions from cancer to male infertility. These products are formed by cerium combining to oxygen obtaining a strong crystalline structure &amp;lt;ref name=Xu&amp;gt;Xu, C., &amp;amp; Qu, X. (2014). Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Materials, 6(3), e90. http://dx.doi.org/10.1038/am.2013.88&amp;lt;/ref&amp;gt;. CNPs have the ability to interchange Ce 3+ and Ce 4+ ions that are present on its surface, leading to defects in oxygen within its crystal lattice structure. These regions on the surface of CNPs are ‘reactive sites’ to attract free radicals &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. A research team experimented on male rats to observe CNP effects on male health and infertility, providing further evidence that oxidative stress plays a key role in preventing proper spermatogenesis &amp;lt;ref name=PMID26097523&amp;gt;&amp;lt;pubmed&amp;gt;26097523&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore, the electronic structure of CNPs, and thus its antioxidant properties make this material a promising therapeutic for male infertility caused or affected by oxidative stress. &lt;br /&gt;
&lt;br /&gt;
'''3. Vitamin E and C'''&lt;br /&gt;
: Vitamin E is a fat – soluble antioxidant that exists in 8 chemical forms of different biological activity. The only form of vitamin E required by the human body is alpha-tocopherol &amp;lt;ref name=Wen&amp;gt;Wen, J. (2006). The Role of Vitamin E in the Treatment of Male Infertility. Nutrition Bytes, 11(1), 1-6. Retrieved from http://escholarship.org/uc/item/1s2485fw&amp;lt;/ref&amp;gt;. This chemical compound is found in various foods such as wheat germ oil, sunflower seeds and oil, and almonds &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Currently, the recommended dietary allowance (RDA) of vitamin E is 15 mg with an adult maximum of 1000 mg &amp;lt;ref name=National&amp;gt;National Institutes of Health,. (2013). Vitamin E — Health Professional Fact Sheet. Ods.od.nih.gov. Retrieved 7 October 2015, from https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/&amp;lt;/ref&amp;gt;. Due to the ability for vitamin E to prevent the peroxidation of PUFA, it has extremely positive implications on infertile men as spermatozoa have high levels of these compounds. From previous studies, vitamin E (alpha – tocopherol) levels decreased to 66.54% and 66.04% in oligospermic and azoospermic males respectively compared to fertile men &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;11225982&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. Therefore there is a positive association between alpha – tocopherol levels and sperm count and motility . &lt;br /&gt;
&lt;br /&gt;
: On the other hand, vitamin C is a water-soluble antioxidant &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. As an electron donor it neutralizes free radicals and also prevents ROS synthesis. As the human body does not produce or store vitamin C, daily intakes of vitamin C – containing foods are required to maintain its levels internally. Such foods with the highest vitamin C content include citrus fruits (oranges), kiwi fruit, broccoli and cauliflower.  The RDA for vitamin C in male adults is 90mg/day &amp;lt;ref name=Evert&amp;gt;Evert, A., &amp;amp; Wang, N. (2015). Vitamin C: MedlinePlus Medical Encyclopedia. Nlm.nih.gov. Retrieved 7 October 2015, from https://www.nlm.nih.gov/medlineplus/ency/article/002404.htm&amp;lt;/ref&amp;gt;. A study published in March 2015 demonstrated that infertile men administered with vitamin C had a significantly better sperm motility rate and morphology. Although it had little/no effect on sperm count, it is still a well recognizable and effective treatment for male infertility &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Traditional Chinese Medicine====&lt;br /&gt;
&lt;br /&gt;
More recently discovered treatments for male infertility involve the hollistic principles of traditional Chinese medicine (TCM). Disregarding the conventional medicines more commonly prescribed in today’s society, the effects of Chinese herbal therapy, massage and acupuncture, have been suggested to improve sperm motility and viability of infertile males &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;.  Acupuncture and massage has been proven to alleviate stress, increase blood flow to reproductive organs, regulate the immune system, and improve dysfunctions in male infertility &amp;lt;ref name=PMID23775386 &amp;gt;&amp;lt;pubmed&amp;gt;23775386&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Additionally, Chinese herbal medicines have been widely used in experiments to prove their beneficial effects on treating infertility. The following are examples of a few herbal therapies that have been investigated.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:100%&amp;quot;&amp;gt;'''Examples of Chinese Herbal Therapies'''&amp;lt;/span&amp;gt; &lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;text-align:center&lt;br /&gt;
|-&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;70px&amp;quot;| '''Herb'''&lt;br /&gt;
! scope=&amp;quot;col&amp;quot; width=&amp;quot;500px&amp;quot;| '''Evidence'''&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Yi Kang Decoction''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| 100 immune infertile males treated with this herb had greater sperm motility, agglutination, and overall increased pregnancy rates in comparison to prednisone, a steroid that reduces sperm antibody levels &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16705853&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #EEEEEE;&amp;quot;| '''Hu Zhang Dan Shen Yin'''&lt;br /&gt;
|style=&amp;quot;height: 50px; background: #EEEEEE;&amp;quot;| 60 treated infertile men showed a higher antisperm antibody reversing ratio than prednisone, thus allows for greater sperm production &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;16970170&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|style=&amp;quot;text-align:center; background: #CCEEEE;&amp;quot;| '''Zhibai Dihuang''' &lt;br /&gt;
|style=&amp;quot;height: 50px; background: #CCEEEE;&amp;quot;| This herb was used to treat 80 cases of male immune infertility in the form of a pill, resulting in increased sperm motility and viability &amp;lt;ref&amp;gt;&amp;lt;pubmed&amp;gt;25632744&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
 &lt;br /&gt;
===Surgical Treatments===&lt;br /&gt;
&lt;br /&gt;
====Varicocele Surgery====&lt;br /&gt;
&lt;br /&gt;
6. &amp;lt;pubmed&amp;gt;25890347&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
This research focuses on a cause for male infertility - varicocele, an enlargement of the pampiniform venous plexus (varicose vein) within the scrotum, with the influence of ROS can lead to atrophy of the testicle. It has been suggested that protein alteration in the seminal plasma and spermatozoa occur in this condition thus the proteins can act as potential biomarkers to diagnose infertility. If diagnosed, males can undergo surgery to treat this.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
7. &amp;lt;pubmed&amp;gt;25885464&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
Discusses the success rate of the microsurgery rat model to treat varicocele that is a causative factor for male infertility. Relates to article number 6&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;26005963&amp;lt;/pubmed&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Ejaculatory Duct Resection====&lt;br /&gt;
&lt;br /&gt;
====Vasectomy Reversal====&lt;br /&gt;
&lt;br /&gt;
===Male Infertility Treatments with Assisted Reproductive Technologies (ARTs)===&lt;br /&gt;
&lt;br /&gt;
It is known that males with fertility problems have little/no chance of conceiving a child with a woman. To address this issue many ARTs have been developed to allow for a successful pregnancy, which all involve the process of sperm retrieval. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Intrauterine Insemination (IUI)====&lt;br /&gt;
&lt;br /&gt;
====In Vitro Fertilisation (IVF)====&lt;br /&gt;
&lt;br /&gt;
====Intracytoplasmic Sperm Injection (ICSI)====&lt;br /&gt;
&lt;br /&gt;
Some ARTs allow for the male's genetic material to be passed onto the offspring, contingent upon a successful sperm extraction/retrieval such as intracytoplasmic sperm injection (ICSI). Although only a spermatozoon (single sperm) is required for this particular procedure, these treatment methods ultimately aim to &amp;quot;maximize the sperm retrieval yield&amp;quot; &amp;lt;ref name=PMID22958644&amp;gt;&amp;lt;pubmed&amp;gt;22958644&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==External Resources==&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Causes_of_Increased_DNA_Damage.jpg&amp;diff=204833</id>
		<title>File:Causes of Increased DNA Damage.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Causes_of_Increased_DNA_Damage.jpg&amp;diff=204833"/>
		<updated>2015-10-09T10:11:42Z</updated>

		<summary type="html">&lt;p&gt;Z3462124: /* Image Reference */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Causes of Increased DNA Damage ==&lt;br /&gt;
&lt;br /&gt;
Factors associated with an increase in the risk of DNA fragmentation resultant in male infertility. &lt;br /&gt;
&lt;br /&gt;
===Image Reference===&lt;br /&gt;
Pankaj Talwar, Suryakant Hayatnagarkar '''Sperm function test.''' J Hum Reprod Sci: 2015, 8(2);61-9&lt;br /&gt;
&lt;br /&gt;
PMID 26157295&lt;br /&gt;
&lt;br /&gt;
===Copyright===&lt;br /&gt;
&lt;br /&gt;
© Journal of Human Reproductive Sciences&lt;br /&gt;
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3462124</name></author>
	</entry>
</feed>